Skip to main content
eLife logoLink to eLife
. 2021 Jul 12;10:e61173. doi: 10.7554/eLife.61173

The role of P2Y12 in the kinetics of microglial self-renewal and maturation in the adult visual cortex in vivo

Monique S Mendes 1, Linh Le 1, Jason Atlas 1, Zachary Brehm 2, Antonio Ladron-de-Guevara 1,3, Evelyn Matei 1, Cassandra Lamantia 1, Matthew N McCall 2, Ania K Majewska 1,4,
Editors: Sonia Garel5, Satyajit Rath6
PMCID: PMC8341987  PMID: 34250902

Abstract

Microglia are the brain’s resident immune cells with a tremendous capacity to autonomously self-renew. Because microglial self-renewal has largely been studied using static tools, its mechanisms and kinetics are not well understood. Using chronic in vivo two-photon imaging in awake mice, we confirm that cortical microglia show limited turnover and migration under basal conditions. Following depletion, however, microglial repopulation is remarkably rapid and is sustained by the dynamic division of remaining microglia, in a manner that is largely independent of signaling through the P2Y12 receptor. Mathematical modeling of microglial division demonstrates that the observed division rates can account for the rapid repopulation observed in vivo. Additionally, newly born microglia resemble mature microglia within days of repopulation, although morphological maturation is different in newly born microglia in P2Y12 knock out mice. Our work suggests that microglia rapidly locally and that newly born microglia do not recapitulate the slow maturation seen in development but instead take on mature roles in the CNS.

Research organism: Mouse

Introduction

Microglia are the brain's resident tissue macrophages (Crotti et al., 2016; Ginhoux et al., 2010) with a developmental origin that is distinct from other macrophages (Ginhoux et al., 2010). In mice, microglial progenitor cells derive from the yolk sac and populate the brain before the blood-brain barrier forms (Ginhoux et al., 2010; Kierdorf et al., 2013) slowly acquiring mature gene expression over two to three weeks (Bennett et al., 2016). In both the rodent and human brain, microglial numbers are maintained throughout adult life (Réu et al., 2017; Füger et al., 2017; Hashimoto et al., 2013), with no further contribution of peripheral macrophages to the microglial population in the absence of pathological changes (Ajami et al., 2007; Askew et al., 2017; Bruttger et al., 2015; Elmore et al., 2015; Mildner et al., 2007). Microglia are uniformly distributed in a distinct cellular grid throughout the brain parenchyma (Nimmerjahn et al., 2005; Eyo et al., 2018; Hefendehl et al., 2014) and maintain their territories with slow translocation on a timescale of days (Eyo et al., 2018).

Although microglia are long-lived cells, they do self-renew slowly under physiological conditions (Füger et al., 2017). To study microglial self-renewal, recent studies have pharmacologically and genetically depleted microglia and uncovered a remarkable capacity for rapid repopulation of the microglial niche without a contribution of infiltrating monocytes (Ajami et al., 2007; Elmore et al., 2015). Early studies in fixed sections from mice following depletion suggested that microglia rapidly repopulate, possibly through a microglial progenitor population which can divide in large proliferative macroclusters from which newly born microglia migrate throughout the brain (Bruttger et al., 2015; Elmore et al., 2014). More recent studies have shown that surviving microglia divide and transiently express nestin; however, none of the repopulated microglia derive from nestin progenitors (Huang et al., 2018a; Huang et al., 2018b; Zhan et al., 2019). Similar to repopulation in the cortex, microglial repopulation in the retina is driven by remaining microglia; however, proliferation occurs in the central retina, suggesting a specific site of microglial generation in the eye (Huang et al., 2018b; Zhang et al., 2018). In the retina, repopulated microglia eventually adopted the dynamic features of endogenous microglia before depletion (Zhang et al., 2018), and repopulated cortical microglia also have expression patterns similar to those of endogenous microglia 30 days after repopulation (Bruttger et al., 2015; Huang et al., 2018b; Zhan et al., 2019). Genomic analysis of newly born cortical microglia shows that new microglia within days of repopulation recapitulate developmental expression profiles (Elmore et al., 2015; Zhan et al., 2019), suggesting that they may undergo a stepwise maturation after repopulation that resembles developmental maturation.

Microglia are highly dynamic, and understanding their behavior requires an equally dynamic approach that monitors their characteristics chronically over time in their native milieu. Here, we characterized microglial ontogeny and maturation in the adult visual cortex using time-lapse imaging in vivo in awake young adult mice after microglial depletion. We show that microglial self-renewal is slow under basal conditions, with microglia maintaining their territories and showing little movement, loss, or proliferation. In agreement with previous studies, we show that, following depletion, newly born microglia rapidly repopulate the brain and acquire equal cell-to-cell spacing reminiscent of baseline conditions. Self-renewal is driven locally by residual microglia, which have a capacity for fast and continued self-division. To determine whether other mechanisms such as migration from sites outside of the imaging area contributed to the increase in microglia numbers, we mathematically modeled microglial self-renewal in vivo and showed that the observed division rates could account for the rapid repopulation. Finally, we showed that newly born microglia quickly acquire ramified morphologies and dynamic surveillance capabilities in response to focal injury, suggesting that microglial functional maturation is remarkably rapid in the adult brain and does not recapitulate developmental features. To dissect the underlying mechanisms responsible for our observations of microglial repopulation, we considered signaling pathways in microglia associated with migration, microglial motility, and maturation. While there are many receptors expressed by microglia that respond to changes in their environment, we focused on the P2Y12 receptor. P2Y12 is highly expressed exclusively in microglia in the brain (Bennett et al., 2016) and regulates microglial translocation under physiological conditions in vivo (Haynes et al., 2006; Eyo et al., 2014). Neither microglial repopulation nor the maturation of newly-born microglia was altered by P2Y12 loss. These findings suggest that the microglia landscape following depletion is restored through a rapid division of remaining microglia, local migration to fill the microglia niche, and fast acquisition of mature characteristics soon after repopulation without the need for P2Y12 signaling.

Results

In vivo imaging of microglia shows limited migration and turnover with preserved territories in the physiological brain

To track microglial turnover in vivo under basal conditions, we imaged microglia daily in the same awake young adult mice using the microglial-labeled CX3CR1-GFP transgenic mouse line (Jung et al., 2000) and a chronic cranial window preparation. Because a growing body of literature suggests that microglia behave differently under anesthesia (Stowell et al., 2019a; Li et al., 2012; Sun et al., 2019), we wanted to capture the dynamics of microglia in the absence of anesthesia to avoid potentially inducing long-term alteration in microglial movement and turnover during repopulation. Microglia in the same cortical area could easily be imaged and tracked from day to day (Figure 1A and Video 1) without overt changes in microglial morphology, which could indicate immune activation over time. Microglia numbers were stable over 14 consecutive days, and individual microglia could be re-identified in the same location daily over this period, suggesting limited local migration and maintenance of microglial territories during this time (Figure 1A). Quantitative three-dimensional nearest neighbor (NN) analysis revealed that microglia generally maintain their territories, whereby each microglia soma lies at ~30 μm from its nearest neighboring microglia. This NN distance remained similar on subsequent days and between animals (Figure 1B, n=3, 16–17 microglia per mouse, 30–40 μm stacks).

Figure 1. In vivo imaging of microglia shows limited migration and turnover in the physiological brain.

(A) A field of microglia in an awake mouse imaged over 14 consecutive days. The dark diagonal lines in the center and top right of the image are blood vessels that remain structurally stable and can be used as landmarks to identify the same location for chronic imaging. Several microglia are identified with the same-colored circles at different time points to show the stability of their somas. (B) Nearest neighbor quantification in 3D demonstrates the distribution of neighboring microglial cells over consecutive days. (C) The translocation index, which captured the average displacement of microglia over time, was ~15 µm when consecutive imaging sessions were compared. (D) The translocation index increased when D1 is compared to imaging carried out later (D2–D14). (E) Microglia translocation between D1-D2, D1-D4, D1-D7, D1-D10, D1-D12, and D1-D14. On average, the majority of microglia remained within ~10 µm away (white bars, circles) from their original location. The number of microglia that moved within their domain (10–30 µm; orange bars, squares), (20–30 µm; blue bars, triangles) or translocated a further distance (>30 µm; gray bars, filled circles) stayed relatively constant with increasing interval between imaging sessions (n=3, 30–40 µm stacks, 13–17 microglia per mouse). Scale bar, 50 μm. Figure 1—source data 1: Source data for microglia turnover and migration in the physiological brain.

Figure 1—source data 1. Source data for microglia turnover and migration in the physiological brain.
Figure 1—source data 2. Source data for CSF1R inhibition in the adult brain.
Figure 1—source data 3. Source data for the Cytokine panel conducted.

Figure 1.

Figure 1—figure supplement 1. CSF1R inhibitor consistently eliminates microglia from the adult brain.

Figure 1—figure supplement 1.

(A–C) Representative maximum intensity projections of confocal images of microglia from the primary visual cortex (V1) in fixed sections of control (A), 7 days PLX (B), and 7 days repopulated (C) mice. (D) Microglial numbers significantly decreased with PLX. n=3–4 animals, average of 3–4 slices per animal. T-test, **p<0.01. Graphs show mean ± s.e.m. Points represent individual animals. Scale bar, 50 µm. Figure 1—source data 2: Source data for CSF1R inhibition in the adult brain.
Figure 1—figure supplement 2. No change in inflammatory milieu following microglial depletion.

Figure 1—figure supplement 2.

(A–L) A combination of anti-inflammatory and pro-inflammatory cytokines including IL-1b, IL-4, IL-6, IL-10, and TFNα were tested using a Multiplex Assay. Each experiment was assayed in triplicate. n=seven animals. T-test, ns. Graphs show means ± s.e.m. Points represent individual animals. Figure 1—source data 3: Source data for the Cytokine panel conducted.

Video 1. Example in vivo two-photon imaging in awake adult mice.

Download video file (5.3MB, mp4)

Two-photon in vivo images were obtained in CX3CR1-GFP awake mice following three consecutive days of training and habituation to the setup with a 1.5x zoom. This video shows a 100-slice z-stack starting at the pial surface and going deeper into the brain in a control awake animal. Microglia are evenly spaced and maintain this organization over many imaging sessions under control conditions. (Microglia are green). Scale bar, 50 µm.

Microglial distribution over time was assessed with a custom algorithm that compared the location of microglia in the same field of view over the 14-day imaging period. To measure microglial movement, we defined a ‘translocation index,’ which was an average distance between the location of each microglia on day 1 and the location of the nearest microglia on an nth day (n=3, 16–17 microglia per mouse, 30–40 μm stacks). On average, microglia shifted on the order of 15 μm from day to day (Figure 1C). This number increased as the two imaging sessions were further apart in time (Figure 1D), possibly due to tissue distortion over time. In general, most microglia did not move by more than 10 μm in either short (1–2 day), (1–4 day), (1–7 day) and long (1–10 day), (1–12 day), (1–14 day) comparisons. The proportion of microglia that moved more than 30 μm (the territory of single microglia) was small in both short and long-term comparisons (Figure 1D–E, n=3, 16–17 microglia per mouse, 30–40 μm stacks). Overall, this analysis suggests that microglia are stable under basal conditions and show limited movement within their territory over 14 days.

Microglia rapidly replenish after partial depletion in the visual cortex

Microglial homeostasis is tightly regulated under basal conditions. Therefore, to explore microglia self-renewal in the visual cortex, we used an established paradigm that partially depletes microglia using PLX5622 (PLX), a Colony Stimulating Factor 1 Receptor (CSF1R/c-kit/Flt3) inhibitor (Elmore et al., 2014; Dagher et al., 2015; Najafi et al., 2018). With the introduction of PLX for 7 days, microglia numbers in the visual cortex decreased by 75% (Figure 2A,B; Figure 2—figure supplement 1), and the 3D NN number increased to 200 μm reflecting the decreased density and therefore increased distance between remaining microglia (Figure 2C). We did not observe changes in cytokine production or astrocyte morphology following depletion (Figure 1—figure supplement 2 and Figure 2—figure supplement 1).

Figure 2. Microglia rapidly repopulate the visual cortex after partial depletion.

(A) A field of microglia during depletion and repopulation imaged in vivo in the same awake mouse. (B) The number of microglia (normalized to control day for each animal) during depletion (PLX) and with repopulation (day 1 day 30). Each line represents an individual animal (n=10, 70–80 microglia per mouse). (C) 3D nearest-neighbor quantification showed a large increase during depletion and the early stages of repopulation before returning to control numbers (n=4, 5–80 microglia per mouse; a subset of mice from (C) that could be imaged throughout the control, depletion, and repopulation time points were used for this analysis). (D) Depletion and repopulation dynamics were similar in the absence of P2Y12 (n=four animals, 5–80 microglia per mouse). (E) 3D nearest neighbor analysis shows similar changes in microglial distribution during repopulation in the absence of P2Y12 (n=3 animals 5-80 microglia per mouse). (F) The ratio of microglia numbers observed on D7 PLX to control. (G) Repopulation was slightly delayed in P2Y12-KO mice as compared to WT, as the change in microglial numbers from depletion (PLX) to day 2 of repopulation was significantly smaller in the absence of P2Y12. (H) By day 5 of repopulation, the change in microglial numbers had normalized between WT and P2Y12-KO mice. (I) Microglial numbers never fully recovered to control conditions in either WT or P2Y12-KO mice (F-I, T-test ns, n=4, 5–80 microglia per mouse). Scale bar, 50 μm. Figure 2—source data 1: Source data of microglial repopulation after partial depletion.

Figure 2—source data 1. Source data of microglial repopulation after partial depletion.
Figure 2—source data 2. Source data for the GFAP expression following microglial depletion.

Figure 2.

Figure 2—figure supplement 1. GFAP expression is unchanged following microglial depletion.

Figure 2—figure supplement 1.

Representative confocal images of astrocytes immunoreacted for GFAP in fixed brain sections from mice in control conditions (A) after PLX treatment (B) and after 30 days of repopulation (C). Qualitatively astrocyte morphology and expression of GFAP did not change following microglial depletion. (D) The proportion of V1 area covered by GFAP-positive astrocytes was unchanged with PLX treatment. n=3–5 animals, one-way ANOVA, Dunnett post-hoc test, ns. Graphs show means ± s.e.m. Points represent individual animals. Scale bar, 20 µm. Figure 2—source data 2: Source data for the GFAP expression following microglial depletion.
Figure 2—figure supplement 2. Comparison of microglial number over the course of repopulation in the presence and absence of P2Y12.

Figure 2—figure supplement 2.

(A) Number of microglia for CX3CR1-GFP (red) and P2Y12-KO (black) animals for each imaging normalized to first control time point. (B–J) There was no significant difference over the course of repopulation. n=4–13 mice per group. T-test, ns. Graphs show mean ± s.e.m. Points represent individual animals. Please note that these comparisons include all animals imaged even if the imaging series was not complete. For the comparisons in Figure 2F–I only animals which had complete imaging were used so that changes between time points in individual animals could be compared directly.
Figure 2—figure supplement 3. Comparison of nearest neighbor distance over the course of repopulation in the presence and absence of P2Y12.

Figure 2—figure supplement 3.

(A) The nearest neighbor quantification for CX3CR1-GFP (red) and P2Y12-KO (black) animals for each imaging time point normalized to the first control time point. (B–J) Differences between genotypes were small but significant at D4 and D21 of repopulation. n=4–13 mice per group, T-test, *p<0.05, **p<0.01. Graphs show mean ± s.e.m. Points represent individual animals.

After discontinuing PLX treatment, we imaged microglial restoration daily in the same mouse to capture the dynamics of this process (Figure 2A). Newly born microglia rapidly repopulated the visual cortex, and microglia numbers were almost completely restored after only 3 days of repopulation. In addition, the newly generated microglia surpassed baseline numbers after 5–7 days of repopulation (Figure 2B). In concert, the 3D NN distance returned to control levels after 3 days of repopulation and remained relatively stable until 30 days of repopulation, the last time point examined, at which time the number of microglia was similar to that of control microglia numbers before PLX treatment (Figure 2C and Video 2). These results suggest that microglial proliferation occurs very rapidly over a 24-hr period starting at ~2 days after cessation of PLX treatment and that microglia rapidly regain their territories within the visual cortex, maintaining their equal spacing and numbers after repopulation is complete.

Video 2. Example in vivo two-photon imaging in awake adult mice during depletion and repopulation.

Download video file (18.3MB, mp4)

Two-photon in vivo images were obtained in CX3CR1-GFP awake mice following three consecutive days of training and habituation to the setup with a 1.5x zoom. This video shows a 100-slice z-stack in the same region during depletion (2D, 4D, 6D, and 7D PLX) and repopulation (D1-D7, D14, D21, and D30). Scale bar, 50 µm.

PLX treatment in P2Y12-KO/CX3CR1-GFP (which will be abbreviated to P2Y12-KO henceforth) mice caused a depletion of microglia of ~70% (Figure 2D), with a concomitant increase in 3D NN (Figure 2E). The change in NN distance was not as profound as in CX3CR1-GFP mice, possibly because these animals had, on average, smaller magnitudes of depletion, although depletion was highly variable across all animals examined irrespective of genotype (Figure 2F). While microglia repopulated in a temporal pattern similar to CX3CR1-GFP mice after cessation of the inhibitor (Figure 2D,E), there appeared to be a slight delay in early repopulation (Figure 2G). However, this delay resolved quickly, and on day 5 and beyond, microglial repopulation matched CX3CR1-GFP controls (Figure 2H,I and Figure 2—figure supplement 2 and Figure 2—figure supplement 3). This suggests that P2Y12 signaling plays a minor role in repopulation dynamics.

Residual microglia are capable of rapid division to generate new microglia and repopulate the cortex

Microglial self-renewal may be driven by local residual microglia that remain following depletion, although the dynamics of this process are poorly understood. It is unclear whether specific subpopulations of remaining microglia are responsible for the division, or all remaining cells have the capacity to divide; whether repopulation is local or originates in a specific brain region and is coupled to large scale microglial migration; and whether repopulating cells do so by single-cell division or through an intermediate multinucleate body that gives rise to multiple new microglia. During the repopulation phase, we observed occasional splitting of existing microglia into two daughter cells (Figure 3), which has been reported previously (Füger et al., 2017; Tay et al., 2017). Both new cells were present in subsequent imaging sessions, indicating that these cells persist and become integrated with the microglial network (Figure 3A).

Figure 3. Microglia self-renewal via residual cells in the visual cortex.

(A) Representative in vivo two-photon imaging of microglial division in CX3CR1-GFP awake mice. Inset is a magnified image of the dividing doublet microglia, which appears as an elongated cell body on day 1 and divides into two cells on day 2. The two microglia then migrated away from one another over the subsequent 2 days. The arrow indicates a cluster of microglia that may represent a multinucleate body but did not generate new microglia during the imaging period. (B) The number of doublet cells per field increased at day 3 day 5 of repopulation (n=3–4, 50–150 microglia per mouse). (C) Doublets made up close to 40% of the total number of microglia at day 4 of repopulation (n=3–4, 50–150 microglia per mouse). The number (D) and percentage (E) of microglial doublets over time were similar in P2Y12-KO mice as compared to WT (n=three animals per group). (F–G) Representative confocal images of microglia from control CX3CR1-GFP mice (F) or mice 2 days after cessation of PLX (peak repopulation) (G) (n=four animals per group). Examples of singlets and doublets are shown with blue and red arrows, respectively. (H) Doublet cells made up ~40% of the total number of microglia quantified during the peak of repopulation. Doublets present after 2 days of repopulation showed an increase in both soma perimeter (I), area (J) and elongation (as defined by the ratio of the lengths of the long to the short axis; K), as compared with singlets and control microglia. (L) Soma elongation plotted against soma perimeter shows separation of the defined morphological states. While, control and singlet microglia overlap, doublet microglia are relatively distinct. (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, T-test, paired (H); One-way ANOVA, Dunnett post-hoc test (I–K)). Graphs show mean ± s.e.m. Each line represents an animal (B–E), points represent individual animals (H), and each dot represents a cell (I–L). Scale bar, 50 μm. Figure 3—source data 1: Source data for microglial repopulation.

Figure 3—source data 1. Source data for microglial repopulation.
elife-61173-fig3-data1.xlsx (180.8KB, xlsx)
Figure 3—source data 2. Galectin three expression in microglia after repopulation.

Figure 3.

Figure 3—figure supplement 1. Galectin three expression in doublet and singlet microglia.

Figure 3—figure supplement 1.

Representative confocal images of microglia in CX3CR1-GFP mice immunoreacted for Galectin 3 (Gal3) in fixed brain sections from mice in control conditions (A) at the peak of repopulation (Day 2) (B). (C-D) Insets of the boxed region in A-B, showing Galectin three positive microglia during repopulation (yellow arrows). Weak Galectin three staining was also observed in microglia in control conditions. (E) While few microglia were Galectin three positive in control conditions, the percentage of Galectin3 positive microglia increased during repopulation, although to a similar degree in singlet and doublet populations. (F) The Galectin three intensity was similar in the doublet and singlet population of microglia during repopulation. n=eight animals per group, One-way ANOVA, Dunnett post-hoc test; (E); T-test (F), **p<0.01, ***p<0.001, ****p<0.0001, ns. Graphs show mean ± s.e.m. Points represent individual animals. Scale bar, 50 µm. Figure 3—source data 2: Galectin three expression in microglia after repopulation.

The characteristic morphologies of microglia in the process of division allowed us to identify ‘potential’ proliferating cells, which we refer to as doublet somas. To determine whether these doublet microglia had distinct morphological characteristics, we analyzed the morphology of microglia in fixed sections from control mice and mice whose microglia repopulated for two days after depletion (peak proliferation; Figure 3F–I). Doublet microglia during repopulation, had larger and more elongated somas than either control microglia or singlet microglia during repopulation although all these parameters overlapped in the three microglia populations (Figure 3I–K). A combination of soma perimeter and soma elongation effectively separated out doublet microglia from singlet microglia after repopulation and from microglia in control animals, showing that doublet microglia have a distinct morphological signature. It is notable that this analysis suggests that singlet microglia show a larger morphological diversity than control microglia, suggesting that newly born microglia themselves may have an altered morphology. Interestingly, Galectin-3 expression was increased in repopulating microglia, although its expression was not statistically significantly different between doublet and singlet microglia (Figure 3—figure supplement 1), recapitulating previous results showing that proliferating microglia can be Galectin-3 positive or negative (Zhan et al., 2020). Additionally, only a subset of doublet cells was Galectin-3 positive.

We quantified both the total number of doublets and the percentage of all microglia that were doublets during our imaging of depletion and repopulation and found that both these measures were increased in the repopulation phase (Figure 3B,C). Similar dynamics of doublet microglia was observed in P2Y12-KO, again suggesting that P2Y12 signaling did not play a large role in regulating microglial division (Figure 3D,E). While these dividing cells could contribute to the rapid increase in microglial numbers observed, three pieces of evidence suggested that other mechanisms may be important. First, in our model of depletion, the number of doublet cells per field increased around day 3 to day 5 of repopulation, but microglia had largely repopulated the brain by day 3 after cessation of PLX. Second, the time scale of the division of each doublet was slow, with microglia remaining in the doublet state for days before dividing, making it unlikely that these cells could create the large increases seen in microglial numbers within 3 days (Figures 2B and 3B,C). Third, the percentage of microglia that were in a doublet state was low even during peak repopulation, and this level of doublets in the microglial population was maintained long after microglial repopulation was complete (Figures 2B and 3B,C).

To determine whether microglia are capable of more rapid division that could account for the rapid increase in microglial numbers seen 2–3 days following cessation of PLX treatment, we imaged awake young adult mice every 4 hr for 24 hr during the most dynamic time of repopulation (Day 2 Day 3; Figure 4). Unlike what we observed during once per day imaging sessions (Figure 2 and Figure 3), a microglial division could be remarkably rapid where doublets separated into two daughter cells in as little as 4 hr (Figure 4B). In an analysis of a subset of divisions where cells could be clearly tracked throughout the 24-hr period (22 total from three animals), we found that 91% of new cells were associated with a characteristic increase and elongation of the cell soma of the original cell before it divided into two microglia. Original microglia often had extensive processes, which were maintained during the division and generation of new microglia (95%), and newly generated microglia frequently had a ramified microglia arbor on the same day that division was complete (82%). Cells generated from these divisions persisted over time, moving away from one another to establish their own territories (100% of cells; Figure 4).

Figure 4. Microglia repopulation in the visual cortex demonstrates that cell division can account for the fast repopulation observed in vivo.

Figure 4.

We imaged CX3CR1-GFP mice every 4 hr for 24 hr during the peak of repopulation (day 2 day 3). We observed a range of behaviors of existing microglia: (A) no division, (B) rapid division on the time scale of 4–8 hr once the doublet appeared, and (C) secondary division, where newly divided microglia underwent another division. (D) Microglial divisions are not spatially regulated. Three microglia in the field of view are divided at different times over the course of 24 hr. (E) The number of microglia during the 24-hr period in the four mice that were imaged. (F) Microglial 3D nearest neighbor distance decreased with time as more microglia were added to the population (n=3). (G) The number of doublets increased during the 24-hr period (n=4). (H) Rapid divisions made up the larger proportion of divisions at each imaging time point compared to secondary divisions (n=4). (I) We tracked identified microglia over time in a small field of view in a subset of animals. The translocation index, which captured the average displacement of microglia over time, was ~8 µm when consecutive imaging sessions were compared (n=3). (J) Microglia translocation between consecutive time points (n=3). On average, the majority of microglia remained within ~10 µm of their original location (white bars). The proportion of microglia that moved within their domain (10–20 µm; orange bars, circles), (20–30 µm; blue bars, squares), or translocated a further distance (>30 µm; gray bars, filled black circles) stayed relatively constant with increasing 4 hr intervals (n=3). (K) In one animal, we categorized microglia over time and determined that when normalized by the total number of microglia at the end of the imaging session, the majority of microglia exhibited a doublet morphology at some point during imaging, and very few microglia exhibited either a persistent normal or doublet morphology (did not divide). Scale bar, 50 μm. Figure 4—source data 1: Source data for microglia repopulation in mice imaged every 4 hr for 24 hr.

Figure 4—source data 1. Source data for microglia repopulation in mice imaged every 4 hr for 24 hr.

While division could be very rapid, the rates of microglia division were not uniform, and some cells divided slower within 8 or 12 hr or remained in the doublet state for the duration of imaging (Figure 4A). Notably, in some cases, we observed cells dividing twice (Figure 4C,D). The first division occurred rapidly, typically within 4 hr, and the cells migrated away from one another. These cells then adopted a doublet morphology and divided again in less than 8 hr (Figure 4C,D). The rate of microglial division did not appear to be spatially regulated as microglia in close proximity divided at different times (Figure 4D). Microglial numbers roughly doubled over this imaging period in our animals (Figure 4E), and 3D nearest-neighbor numbers fell as microglia were generated (Figure 4F). The number of doublet cells also increased but tended to plateau around 12 hr into the imaging period (Figure 4G). In addition, the number of rapid divisions, as well as secondary divisions of newly born microglia also increased (Figure 4H). To determine how mobile microglia were during the peak of repopulation, we tracked a small, identified subset of microglia in three of these animals. Microglia translocation index during 4 hr intervals over 24 hr was ~8 μm (Figure 4I). Overall, most microglia did not move by more than 10–20 μm over the 24 hr. The proportion of microglia that moved 20–30 μm was small during this time course (Figure 4J). More in-depth analysis of one of the animals to track and classify microglia showed that only 7% of microglia during this time did not divide, and 5% of these adopted a doublet morphology that persisted throughout the imaging session, suggesting they may divide at a later time. Of new cells, 20% were born by rapid division, while only 2% of microglia were born of secondary divisions in this mouse (Figure 4K). Overall, this points to a remarkable capacity of the majority of the remaining microglia to divide rapidly and suggests that this rapid division may explain the fast repopulation of the cortex after depletion.

Mathematical modeling of microglial repopulation kinetics in the adult visual cortex

To determine whether local remaining microglia could repopulate the cortex through rapid division, we created a mathematical model (Figure 5; Figure 5—figure supplement 1) which used the division rates of newly-born microglia quantified in the 24 hr imaging experiment (Figure 4) to determine whether these rapid divisions could account for the increases in microglial numbers seen when repopulation was imaged daily (Figure 2). The model considered three parameters: (Crotti et al., 2016) the number of cells in the population on day 2 of the daily imaging paradigm (for each individual animal imaged in Figure 2), (Ginhoux et al., 2010) the probability that a cell will be eligible for division (we tested using proportions ranging from 10 to 100% in increments of 10), and (Kierdorf et al., 2013) the observed division rates of the cells during the peak of repopulation (Figure 4). The simulation was run 500,000 times. A schematic of the model is presented in Figure 5—figure supplement 1. In summary, we randomly sampled the number of cells in the population that are eligible for division from a binomial distribution with probability of success equal to the proportion of cells eligible for division and set that equal to the initial day. We counted the number of cells after 24 hr that divided, as well as all the cells in the process of dividing to account for the total number of cells in the final subtotal. In 4 hr intervals (to replicate the 24 hr imaging experimental time points), we resampled cells from the population of those eligible for division (total number of cells in circulation minus cells previously selected for division) and corresponding division rates before concluding after 24 hr passed. The empirical p-value is calculated from the simulated data by taking the percentage of the repopulation simulation results where the final number of microglia was greater than or equal to the number of microglia observed on day 3 of the daily imaging paradigm for each animal (Figure 2). The empirical p values vs. the cell division probability were plotted from the simulation with a 4 (Figure 5A) and 8 hr delay (Figure 5B) between divisions. With 50% of cells available for division, it is reasonable to believe that the repopulation we observed from days 2 to 3 in our daily imaging experiments in 11 animals (Figure 2) came purely from local doublet cell division if 50% of cells are capable of division (Figure 5A–B). In fact, in half of the animals imaged, only 10% of cells would need to be capable of division to repopulate the visual cortex. This data suggests that the local division of remaining microglia is likely responsible for rapid repopulation with newly born microglia capable of further division and without the need for the migration of newly generated microglia from a different site of generation.

Figure 5. Mathematical modeling of microglial repopulation.

(A–C) Mathematical modeling of microglial repopulation using measured kinetic parameters. Empirical ρvalues from the simulation are plotted for a minimum 4 hr delay (A) and 8 hr delay (B) between subsequent divisions; each animal is represented by a line (n=10). Figure 5—source data 1: Source data for the mathematical modeling of microglial repopulation.

Figure 5—source code 1. Code to generate the mathematical model simulation.
Figure 5—source data 1. Source data for the mathematical modeling of microglial repopulation.

Figure 5.

Figure 5—figure supplement 1. Mathematical model of adult microglia repopulation.

Figure 5—figure supplement 1.

A schematic to demonstrate the steps of the mathematical model and the cells that were used to estimate the total population of cells at the end of 24 hr. In this example, we start N0=4 (there are four microglia at t=0), p=0.5 (the probability of each of these cells undergoing a division is 0.5), and R=(4,8,12), which represents the observed division rates in vivo which were 4, 8, and 12 hr with a probability of (0.25,0.5,0.25), reflecting the fact that half the cells took 8 hr to divide, while a quarter tool 4 hr and another quarter took 12 hr. T=0: Given p=0.5, one cell (yellow) will undergo division and will take 4 hr to divide (as sampled from R). T=4: The dividing cell is removed from the dividing population and assumed to be refractory for 4 hr once division is complete. This is indicated by the two yellow 'dividing cells at the bottom of the panel'. The remaining three cells from t=0 are now eligible for division. Given p=0.5, two cells will divide at this time point with rates of 4 and 8 hr as sampled from R. T=8: The two dividing cells from t=four have reentered the dividing population, and now three microglia are eligible for division while two microglia are actively dividing after t=4. One microglia (brown) will divide at this time point with a 12 hr division rate (as sampled from R). T=24: This process is repeated iteratively, until the last time point when 18 microglia are present in the population. This procedure was used to model data from daily imaging experiments (Figure 2) using N0 as the number of microglia present in each animal on day 2. Figure 5—source data 1: Source data for the mathematical modeling of microglial repopulation. Source code-Figure 5—source data 1: Code to generate the mathematical model simulation.

Newly born microglia acquire a hyperramified morphology in the later stages of repopulation

We observed that doublet cells were ramified during division, resulting in new cells that also had ramified morphologies soon after they separated. Because microglial morphology is difficult to quantify in the wide-field imaging in awake animals, we imaged a subset of microglia during repopulation under anesthesia in a separate cohort of animals at high digital zoom to closely quantify the subtle changes in repopulated microglial morphology (Figure 6A). We then traced individual microglia and used Sholl analysis to assay the complexity of the arbors (Figure 6B and Figure 6—figure supplement 1). At the peak of depletion (7 days of PLX), the remaining microglia exhibited a ramified morphology with extensive processes similar to the basal microglia process ramification under steady-state conditions (Figure 6B–C) and an increase in soma size that was not statistically significant (Figure 6F). In the early phase of repopulation (day 1 – day 3), the newly born microglia appear ramified with secondary processes (Figure 6B–E) and have an enlarged soma (Figure 6F). After this, a more complex arbor begins to form (Figure 6B–E), whereby there is an overshoot in the maximum number of intersections and the integrated area under the Sholl curve at 5 days of repopulation, which coincides with our increase in the number of microglia in our original repopulation data (Figures 2B and 5C). This slight hyperramification is maintained for as long as we imaged (30 days of repopulation; Figure 6C–D), despite a return to baseline numbers of microglia (Figure 3B) and a return to a smaller soma size and full width half max quantification (Figure 6E–F). P2Y12-KO animals were hyporamified as compared to CX3CR1-GFP mice at baseline (Figure 6—figure supplement 1) and did not show the hyperramification following repopulation as observed in the CX3CR1-GFP mice (Figure 6G–K; Figure 6—figure supplement 1), although similar changes in soma size were observed (Figure 6K). Therefore, newly born microglia rapidly acquire complex morphologies in a process that is independent of P2Y12. However, newly born microglia exhibit a chronic hyperramification that distinguish them from microglia in control conditions. This hyperramification does not occur in the absence of P2Y12.

Figure 6. Newly born microglia remain in a hyperramified state after repopulation.

(A) Individual microglia imaged in CX3CR1-GFP and P2Y12-KO mice during control, depletion (7 days of PLX), and repopulation (7 and 30 days). (B) Sholl profiles summarizing the morphology of microglia during depletion and repopulation. (C) Microglia have an increased number of maximum intersections in the later time points of repopulation; note the increased arborization after day 5 (d) Microglia have a greater AUC (Area under the curve) in the later stages of repopulation. (E) The full width half max measurement showed a change between the PLX and the later stages of repopulation (D30) n=3–13 animals per group, 2–4 microglia per mouse, (*p<0.05, **p<0.01, ***p<0.001, One-way ANOVA, Dunnett post-hoc test). (F) Microglia demonstrated a greater soma area during the early stages for repopulation n=4–9 animals per group, n=3–6 microglia per mouse, (*p<0.05, **p<0.01, One-way ANOVA, Dunnett post-hoc test). (G) Sholl profiles for P2Y12-KO mice during depletion and repopulation. There was no significant difference in the maximum intersections (H), area under the curve (I) and Full width half max (J) of the Sholl curves in the absence of P2Y12 (n=4–11 microglia per mouse, ns, One-way ANOVA, Dunnett post-hoc test). (K) Microglia demonstrated a greater soma area during the early stages for repopulation n=4–9 animals per group, n=3–6 microglia per mouse, (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, One-way ANOVA, Dunnett post-hoc test). Graphs show mean ± s.e.m. Points represent individual animals. Red circles (C–F) represent CX3CR1-GFP animals while black circles (H–K) represent P2Y12-KO animals. Scale bar, 20 μm. Figure 6—source data 1: Source data for the morphology and soma area of Newly-born microglia.

Figure 6—source data 1. Source data for the morphology and soma area of newly born microglia.

Figure 6.

Figure 6—figure supplement 1. Comparison of microglial morphology over the course of repopulation in the presence and absence of P2Y12.

Figure 6—figure supplement 1.

(A–E) Average Sholl profiles of CX3CR1-GFP (red) and P2Y12-KO (black) animals for each imaging time point. (F–J) Quantification of the maximum intersections of the Sholl profiles showing that microglia in the absence of P2Y12 are less complex at baseline and take on a more hyperramified phenotype as compared to CX3CR1-GFP during repopulation. (K–O) The area under the curve also decreased as compared to CX3CR1-GFP mice during repopulation (control day, PLX, 1–2 days, 14–21 days, and 30 days repopulation). n=4–13 mice per group, 2–5 microglia per mouse, One-way ANOVA, Dunnett post-hoc test, *p<0.05, **p<0.01, ***p<0.001, ***p<0.0001. Graphs show mean ± s.e.m. Points represent individual animals.

Newly born microglia are dynamic and survey the brain

Given the changes in microglial morphology after repopulation (Figure 6), we set out to determine if the differences were also reflected in their dynamics (Figure 7). Motility measurements were carried out under anesthesia as adrenergic signaling in the awake condition dampens microglial dynamics (Stowell et al., 2019a; Sun et al., 2019; Liu, 2019), allowing us to reliably track microglial process extension and retraction on the order of minutes (Figure 7A–C). PLX treatment led to only a modest decrease in motility (Figure 7D), as imaged over a 1-hr period, suggesting that the 20–30% of microglia that remain after depletion, not only have full arbors, but are motile and can effectively interact with elements in the parenchyma. This decrease in motility was accompanied by a small decrease in the instability index, which measures the retraction of stable processes (Figure 7E) and a small increase in the stability index, which measures the stabilization of newly extended processes (Figure 7F), although neither of these changes reached statistical significance. As new microglia were generated after depletion, microglial motility recovered such that the increase in movement correlated with the increase in the number of microglia over time. In addition, during the later stages of repopulation (day 21 day 30), we found no significant difference in basal microglia process motility and long-term stability as compared to baseline (Figure 7D–F). Combined with our previous data on microglia repopulation, these data suggest that repopulation can be divided in two stages: early and late repopulation. As microglia mature in the later stages of repopulation (day 7 – day 30), they exhibit more complex arbors suggesting a dysregulation in their morphology. This long-term change in morphology, however, does not impact microglial motility which resembles basal microglial states (Figure 7D). To complement the morphology assessment (Figure 6), we set out to determine the dynamics of newly born microglia in P2Y12-KO mice. Overall, during the early and late stages of repopulation, we did not observe any changes in motility indices in these mice (Figure 7G,H,I and Figure 7—figure supplements 13). However, P2Y12 KO mice appeared to have lower motility in the early stages of repopulation (D1-D3), as well lower instability and stability indices than CX3CR1-GFP mice (Figure 7—figure supplements 13).

Figure 7. Newly born microglia are dynamic and survey the brain.

(A) Example of motility analysis showing the original microglia image, (B) Thresholded microglia (C) and a visual representation of microglial motility whereby thresholded imaged from two time points are combined with magenta representing retraction, green representing extension and white representing stable pixels. (D) Quantification of the motility index which compared the gain and loss of pixels across 5 min intervals. Microglia motility was decreased during depletion but recovered quickly with repopulation. (E) A similar trend toward decreases during depletion was observed in the instability index which was calculated as the proportion of stable pixels that retracted over the total stable pixels in the first time point. (F) No change in the stability index (the proportion of extended pixels that became stable divided by the total extended pixels in the first overlay) was observed (n=4–17 animals per group, *p<0.05, **p<0.01, ***p<0.001, One-way ANOVA, Dunnett post-hoc test). (G–I) There was no significant change in motility (G), instability (H) and stability (I) indices in the absence of P2Y12 (n=4–9 animals per group, ns, One-way ANOVA, Dunnett post-hoc test). (J) Maximum projection of microglial processes over the hour imaging session to observe surveillance (control, 7 days of PLX, 7 days of repopulation and 30 days of repopulation). (K) Microglial surveillance of the parenchyma dropped as microglia were depleted from the brain but recovered quickly during repopulation as soon as microglial numbers reached control levels (1 day −3 day). (L) Graph of surveillance normalized to the extent of microglial coverage in the first time point (n=4–17 animals per group, **p<0.01, ***p<0.001, ****p<0.0001 One-way ANOVA, Dunnett post-hoc test). (M) Microglial surveillance of the parenchyma dropped as microglia were depleted from the brain in the absence of P2Y12 but recovered quickly as shown in the CX3CR1 controls in (L). (N) Graph of surveillance normalized to the extent of microglial coverage in the first time point in the absence of P2Y12 (n=3–6 animals per group, **p<0.01, ***p<0.001, ****p<0.0001, One-way ANOVA, Dunnett post-hoc test). Graphs show mean ± s.e.m. Points represent individual animals. Scale bar, 50 µm. Figure 7—source data 1: Source data for Newly born microglia motility, surveillance during depletion and repopulation.

Figure 7—source data 1. Source data for newly born microglia motility, surveillance during depletion and repopulation.

Figure 7.

Figure 7—figure supplement 1. Comparison of motility over the course of repopulation in the presence and absence of P2Y12.

Figure 7—figure supplement 1.

(A) The motility index for both CX3Cr1GFP/+ (red) and P2Y12KO (black) animals. (B–F) While there was a slight reduction in motility in P2Y12KO animals in the early stages of repopulation (D1–D3), motility was largely comparable in the two genotypes. n=4–13 mice per group, 2–5 microglia per mouse, T-test, *p<0.05. Graphs show mean ± s.e.m. Points represent individual animals.
Figure 7—figure supplement 2. Comparison of changes in the instability index over the course of repopulation in the presence and absence of P2Y12.

Figure 7—figure supplement 2.

The instability index is the proportion of stable pixels that retracted over the total stable pixels in the first time point. (A) The instability index in both CX3CR1-GFP (red) and P2Y12-KO (black) animals. (B-F) A significant decrease in the instability index was observed at control time points and in the early stages of repopulation. n=4–13 mice per group, 2–5 microglia per mouse, T-test, *p<0.05, ***p<0.001. Graphs show mean ± s.e.m. Points represent individual animals.
Figure 7—figure supplement 3. Comparison of the stability index over the course of repopulation in the presence and absence of P2Y12.

Figure 7—figure supplement 3.

(A). The stability index (the proportion of extended pixels that became stable divided by the total extended pixels in the first overlay) was compared between the two genotypes. (B–F) P2Y12 KO mice generally had a lower stability index than CX3Cr1 GFP/+ animals throughout the course of the experiment. n=4–13 mice per group, 2–5 microglia per mouse, T-test, *p<0.05, **p<0.01. Graphs show mean ± s.e.m. Points represent individual animals.
Figure 7—figure supplement 4. Comparison of Surveillance in the presence and absence of P2Y12.

Figure 7—figure supplement 4.

(A) Microglial surveillance of the parenchyma compared between CX3CR1-GFP (red) and P2Y12-KO (black) animals for each imaging time point. (B–F) P2Y12 KO animals showed smaller surveillance at the control and PLX time points. n=5–13 mice per group, 2–5 microglia per mouse, T-test, *p<0.05, **p<0.01. Graphs show mean ± s.e.m. Points represent individual animals.
Figure 7—figure supplement 5. Comparison of normalized surveillance in the presence and absence of P2Y12.

Figure 7—figure supplement 5.

(A) Graph of surveillance normalized to the extent of microglial coverage in the first time point compared between CX3CR1-GFP (red) and P2Y12-KO (black) animals for each imaging time point. (B–F) While normalized surveillance was decreased during PLX treatment in the P2Y12 KO animals, it was otherwise comparable across time point. n=5–13 mice per group, 2–5 microglia per mouse, T-test, *p<0.05, **p<0.01. Graphs show mean ± s.e.m. Points represent individual animals.

Finally, to test whether changes in morphology and dynamics of new microglia affect microglial surveillance, we assessed microglial process coverage over one hour (Figure 7J). Following 7 days of PLX, the remaining microglia population survey a much smaller area than observed under basal conditions due to their reduced numbers. Microglial surveillance recovers at day 3 of repopulation when microglial numbers return to baseline values and is maintained until day 30 (Figure 7K). When surveillance was normalized to the process coverage in the first time point (t=0mins) to account for the loss of microglia with depletion, we found that individual microglia surveilled their territory in the same manner throughout the control, depletion, and repopulation conditions (Figure 7L). The surveillance pattern was similar in the absence of P2Y12, although P2Y12-KO microglia appeared to be less efficient at surveilling the brain than CX3CR1-GFP microglia (Figure 7—figure supplement 4). This difference is largely due to the less ramified arbor in P2Y12 KO microglia, as it was less apparent when surveillance was normalized to the first time point to account for morphology (Figure 7—figure supplement 5). Interestingly, it appeared that P2Y12 KO microglia were more efficient at surveying the brain during PLX treatment (Figure 7M–N; Figure 7—figure supplement 5). Based on these findings, we conclude that newly-born microglia mature within days of repopulation, acquire complex arbors, and survey the environment effectively. Also, while P2Y12 may mediate the microglial landscape under basal conditions (Eyo et al., 2018), it likely plays a minor role in newly born microglia ontogeny and maturation (Figures 2, 6 and 7).

Newly born microglia respond robustly to acute focal tissue injury

To determine whether newly-born microglia can carry out their normal pathological functions, we generated focal laser ablation injuries in the visual cortex using the two-photon laser microscope and quantified the movement of microglial processes toward the site of injury over the course of 1 hr using two separate methods (Figure 8 and Video 3). First, we developed a custom optic flow-based algorithm to calculate the directional velocity of microglia processes moving toward the injury site (Figure 8E–F). Analysis of the average of all vectors moving towards the core showed that microglia at all stages of depletion and repopulation responded robustly to laser ablation injury (Figure 8F,G). Both the maximum magnitude and the integrated response (area under the curve) were similar across conditions (Figure 8G,H). It is interesting to note that, under PLX treatment, the remaining microglia, although less motile, sparse, and randomly organized in the cortex, responded robustly to laser ablation injury with only a slight trend toward a decreased response (Figure 8F,G,H). A similar pattern was observed with convergence analysis, which calculates the number of pixels representing microglia processes entering a small ring around the core of the injury site (Figure 8I). Similar to the directional velocity measure, there was no difference in the maximum convergence at 60 min and the area under the curve value at each time point (Figure 8J,K). This suggests that the newly-born microglia during the early phases of repopulation can respond robustly to focal laser ablation injury. This is an indication that microglia retain the necessary sensors such as P2Y12 and internal machinery to respond to injury.

Figure 8. Newly born microglia respond robustly to acute laser ablation injury.

Figure 8.

Example microglial response to focal laser ablation at t=0 min, t=30min and t=55 min after ablation for control (A), 3 days of repopulation (B), 7 days of repopulation (C), and 30 days of repopulation (D). (E) Quiver plot of microglial response. Green arrows correspond to vectors moving towards the core and red arrows correspond to vectors moving away from the core. (F) Graph showing the average vectors moving towards the core following focal laser ablation injury. (G-H; black circles – vector analysis) There were no statistically significant differences observed in the maximum directional response, or the integrated area under the curve over time. The dynamics of the convergence of microglial processes on the injury core n=12 (control), n=3 (PLX), n=8 (7–8 days), n=6 (30 days). (I) Graph showing the convergence towards to core following focal laser ablation injury. (J-K) There was no significant difference in the maximum convergence at 60 min, or the convergence response when assayed using the area under curve of the convergence graphs over time (blue circles – convergence analysis). n=3–12 animals per group, One-way ANOVA, Dunnett post hoc test. Graphs show mean ± s.e.m; ns. Points represent individual animals. Scale bar, 20 µm. Figure 8—source data 1: Source data for newly-born microglia response to acute laser ablation injury.

Figure 8—source data 1. Source data for newly-born microglia response to acute laser ablation injury.

Video 3. Example in vivo laser ablation video during depletion and repopulation.

Download video file (2.7MB, mp4)

Imaging was done in CX3CR1-GFP awake with a 1.5x zoom. Here, we compared a laser ablation during control condition, depletion (PLX), and repopulation (D7) and D30. Microglia responded rapidly during these two conditions. 48 slices total, 12 slices per group. Scale bar, 20 µm.

Discussion

In this study, we characterized in detail the dynamics of adult microglia ontogeny and maturation in the visual cortex of mice. Because microglia behave differently in awake vs. anesthetized states (Stowell et al., 2019a; Sun et al., 2019; Liu, 2019), we used an awake in vivo chronic imaging setup to track microglial repopulation. First, we showed that microglia maintain their numbers and territories under basal conditions. Next, we found that microglia can divide rapidly and continuously to repopulate the brain within a few days after partial depletion with the colony stimulating factor one receptor (CSF1R) inhibitor, PLX, in a manner that is largely independent of signaling through the P2Y12R. A mathematical model based on the imaged kinetics of division confirmed that the repopulation was driven by very rapid, local self-renewal by surviving microglia, which transition to a doublet morphology, divide, and migrate apart before undergoing the next cycle of division. Finally, we found that newly born microglia mature rapidly both structurally and functionally and that P2Y12 modulates morphological changes following repopulation.

The dynamics of microglial division are heterogeneous

Microglia are thought to be long-lived cells, self-renewing slowly and stochastically under unperturbed physiological conditions in the brain with an average lifetime of four years in the human cortex (Réu et al., 2017), and 15 months in the mouse (Füger et al., 2017). Despite their stability, microglia can rapidly repopulate the brain when their niche has been depleted (Bruttger et al., 2015; Elmore et al., 2015). While this remarkable capacity for self-renewal has been the subject of intense interest, many questions remain unanswered, regarding the kinetics of microglia self-renewal. By taking a chronic in vivo approach coupled with mathematical modeling, we were able to identify and track novel behaviors of residual and dividing microglia in vivo. Based on the average cell numbers and the various cell division rates, our simulations of microglia repopulation support the conclusion that the residual cells that remain after depletion can rapidly divide to repopulate the visual cortex.

We observed that during the height of repopulation, ~50% of cells adopted a doublet morphology indicative of an impending division, suggesting that most residual cells are capable of proliferating, and 95% of those cells divided in a 24-hr period. While we also observed these doublet morphologies after repopulation was complete, the division rates at that time were slow with division occurring over a period of days, as seen in the non-depleted brain (Füger et al., 2017), and inconsistent with rapid repopulation. In contrast, at the height of repopulation, division could occur very rapidly, with a cell adopting a doublet morphology and undergoing division within 4 hr. These rapidly dividing cells can undergo a secondary division within our 24-imaging period. This secondary division could occur in both cells generated from the first division, suggesting a remarkable capacity for proliferation in residual microglia.

However, the rates of microglia division were not uniform. While some cells divided rapidly and repeatedly, others divided slowly within 8 or 12 hr or remained in the doublet state for the 24-hr period of imaging. While we cannot discern whether these differences in division rates are tied to specific subpopulations of microglia, it is well known that microglia are morphologically and transcriptionally diverse, with high-throughput single-cell transcriptomics identifying distinct subpopulations of microglia with unique molecular signatures that change with age and in response to insults (Hammond et al., 2019; Ayata et al., 2018; Li et al., 2019). This heterogeneity in microglia is also seen across various brain regions (Hammond et al., 2019; Ayata et al., 2018; O'Koren et al., 2019; De Biase et al., 2017). Similar heterogeneity in the residual microglial population may play a role in the dynamics of repopulation, contributing to a heterogeneity in the capacity to divide. For instance, it has been suggested that the remaining microglia after depletion are a specialized CSF1R-inhibitor resistant population of Galectin-3-progenitor-like microglia (Zhan et al., 2020). We did not see a correspondence between our doublet morphologies and Galectin-3 expression, which supports the idea that proliferating cells can be Galectin-3 positive or negative (Zhan et al., 2020), although other factors could define proliferating microglial populations. A similar scenario has been observed in the retina where microglia repopulate from a distinct source and migrate through the optic nerve to repopulate the rest of the retina (Huang et al., 2018a). While more detailed studies will be needed to determine the extent of microglial heterogeneity after PLX treatment, characterizing the heterogeneity of repopulating microglia may provide new avenues for understanding the phenotypes of adult-generated vs. yolk sac born microglia.

Newly generated microglia rapidly recapitulate functional features of endogenous microglia

We show that newly born microglia acquire mature characteristics such as baseline motility, surveillance, and response to acute laser ablation remarkably quickly. In fact, dividing doublet microglia have an extensive, motile arbor which is maintained through the division such that the two resulting cells already have extensive processes which surveil the environment and can respond to injury. While microglial expression in newly repopulated microglia recapitulates some aspects of neonatal microglia expression patterns (Zhan et al., 2019; Zhan et al., 2020), we did not observe the typical morphologies of microglia or changes in process dynamics and responses to injury that could indicate a less mature phenotype. Developing microglia transition from an ameboid morphology to a ramified morphology at around post-natal day 30 (Orłowski et al., 2003), and while microglial dynamics have not been extensively studied in development, early life microglia have few processes and are migratory (Kierdorf et al., 2013; Hoeffel et al., 2015; Ginhoux et al., 2013). Since newly born microglia did not exhibit ameboid morphologies, and somas tended to not move more than 10–20 µm, this suggests that if microglia do revert to a developmental program when they are first generated in the adult brain, this program does not significantly alter their physiological functions. Alternately, they may go through an accelerated maturation program, as expression also matures much faster than the stepwise development of microglia over a period of weeks in early life (Zhan et al., 2019; Bennett et al., 2016; Matcovitch-Natan et al., 2016).

Changes in microglial morphology in newly born microglia

While many studies have shown that after 30 days of repopulation, new microglia largely adopt the gene expression profile of control microglia (Elmore et al., 2015; Zhan et al., 2019), several observations in our study suggest that adult born microglia may not be identical to their yolk-sac-generated counterparts. We found that after repopulation, microglia morphology changed with a hyper-ramification of the processes and that more microglia adopted a doublet-like morphology with an elongated cell body. As these changes persisted for a month after the cessation of PLX, it may be that newly born microglia take on a unique phenotype that persists long after microglia are mature. While hyper-ramification of the microglial arbor was observed in CX3CR1-GFP animals, it was not apparent in P2Y12-KO animals, possibly due to the general effects of P2Y12 loss on ramification at baseline (Sipe et al., 2016). Hyper-ramification of microglia is typically associated with periods of enhanced plasticity such as that following monocular deprivation in the developing visual cortex (Huang et al., 2018b) and with chronically stressed animals in a model of posttraumatic stress disorder (PTSD) (Smith et al., 2019) where microglia transition from their normal ramified morphology to a hyper-ramified state, characterized by an increase in primary and secondary processes. A similar microglial response, which has been referred to as arrested hyper-ramification, is also observed during aging and in response to specific neurotoxins (Streit et al., 1999; Streit et al., 2004). Whether this chronic morphological change is a product of the rapid repopulation and efforts to restore homeostasis, a direct result of PLX treatment, or a general phenotype of newly-born microglia is unclear.

The presence of a persistently increased number of microglia with elongated, doublet-like cell bodies, after repopulation, could be indicative of further morphological alteration of newly born microglia, but it could also suggest an increased capacity for division as similar doublets have been identified as a source of dividing cells in another study (Füger et al., 2017). If Galectin-3+ microglia that remain after depletion Zhan et al., 2020 have increased capacity for division, they may divide to produce new microglia that are distinct from yolk sac-generated microglia and rapidly take on mature characteristics, contributing to a different phenotype of adult vs. yolk-sac born microglia. The Galectin-3+ cells may remain in the population as persistent doublet cells primed for division and self-renewal. Thus, while adult born microglia appear to rapidly take on their mature roles in the brain, their characteristics may differ in subtle ways from microglia that are generated in the yolk sac and populate the brain in development.

Newly generated microglia chronological versus biological age

Functional characterization of newly born microglia may provide valuable clues for determining treatments for neurodegenerative and neurodevelopmental diseases where microglia are often thought to be dysregulated (Perry et al., 2010; Keren-Shaul et al., 2017; Krasemann et al., 2017). It is possible that efficient rejuvenation of old ‘senescent’ microglia in the diseased brain with new microglia through depletion and repopulation can generate a new population of microglia with improved functions (Rice et al., 2015; Spangenberg et al., 2016; Elmore et al., 2018). However, it is important to recognize that it remains unclear whether the chronologically younger newly born cell is also biologically younger. In fact, we do not yet understand the biological process of microglia repopulation, and it is not known whether the division of microglia is symmetrical or asymmetrical. To determine whether a newly divided cell is in fact, ‘rejuvenated,’ the ‘maturity’ of that cell will need to be tested directly. This could be assessed by looking at transcriptional and epigenetic signatures and comparing to similar studies done in development (Hammond et al., 2019; Matcovitch-Natan et al., 2016). Newly born microglia may go through a stepwise expression program that partly recapitulates development, giving them younger functional characteristics, or they may acquire all the epigenetic and cytoplasmic features of their ‘aged’ parent cell, leading to repopulation but not ‘rejuvenation’ of the microglia niche (Zhan et al., 2019). This latter option could also explain why the newly-born cells acquire mature characteristics and functions early in the repopulation phase.

Intrinsic and extrinsic mechanisms of microglia repopulation

A combination of exogenous and endogenous signaling mechanisms may contribute to microglia rapid repopulation and spatial organization. Recent evidence has shed light onto some of the extracellular signals that shape repopulation, including those that regulate microglia proliferation such as colony stimulating factor 1 (CSF-1) and interleukin one receptor (IL1R), and those that regulate migration such as fractalkine through its receptor, CX3CR1 (10, 11, 20). A gradient or threshold of these factors may start intracellular cascades in microglia that trigger division and migration, such as NF-ΚB signaling, which has been shown to be important for microglia to repopulate fully (Zhan et al., 2019). In addition, we show that the P2Y12 receptor does not modulate newly born microglial maturation (Figures 6 and 7F) despite effects of P2Y12 loss on microglia ramification (Figure 6—figure supplement 1Haynes et al., 2006; Sipe et al., 2016), and it does not affect doublet formation, repopulation, or the acquisition of microglial territories (as reflected by changes in nearest neighbor quantification) in the visual cortex (Figures 2 and 3). This is surprising given that P2Y12 modulates microglial translocation in baseline conditions (Eyo et al., 2018). All together, this suggest that microglia repopulate and mature in a P2Y12-independent manner. The progressive distribution of microglia to achieve tiling during repopulation is most likely maintained by lateral inhibition mechanisms and homeostatic microglia-specific genes such as Sal1 and Mafb—which both maintain microglia in a ramified nonclustered state (Matcovitch-Natan et al., 2016; Buttgereit et al., 2016). Because microglial numbers overshoot their target during the early stages of repopulation, it is also likely that astrocytes may be recruited to phagocytose excess newly-born microglia, and these cells may contribute to the extracellular environment that promotes microglial migration and maturation. Altogether, an interplay of diverse factors likely contributes to microglia homeostasis following depletion, which may include endogenous mechanisms at play in specific populations of microglia, including Galectin-3+ cells, as well as exogenous factors that come from microglia, neurons, and astrocytes and work together to re-establish microglia numbers in the adult brain.

Concluding remarks

Together our results build on current adult microglia ontogeny research showing that rejuvenation of adult microglia is driven by stochastic doublet cell division locally during repopulation, with newly born cells rapidly able to take on their roles in the brain. Loss of P2Y12 impacts microglial morphologies during repopulation but seems to play a minor role in microglial division. In addition, our mathematical modeling supports the idea that division of residual microglia alone can fill the microglia niche following depletion. While our in vivo tracking approach illuminates the rapid and heterogeneous dynamics of microglial repopulation, future studies will be needed to fully understand the mechanisms that lead to the generation of new microglia and their ability to adopt their mature features. Such studies will provide a deeper understanding of the important role microglia play in homeostasis and disease.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional information
Strain, strain background CX3CR1-GFP, C57/Bl6 background (Mouse) JAX RRID:IMSR_JAX:005582
Jax stock #005582
B6.129P2(Cg)-Cx3cr1tm1Litt/J
Male and Females used in our study
Strain, strain background P2Y12 KO, C57/Bl6 background (Mouse) Courtesy of Maiken Nedergaard lab via a Materials transfer agreement Mice were generated by the Conley lab doi:10.1172/JCI17864.
Male and Females used in our study
Chemical compound, drug PLX5622 drug Research Diets, New Jersey, USA AIN76A-D1001i PLX5622 drug from Plexxikon Inc, Berkeley, CA, USA
Chemical compound, drug Fentanyl (0.05 mg/kg) University of Rochester Medical Center Pharmacy
Chemical compound, drug Midazolam
(5.0 mg/kg)
University of Rochester Medical Center Pharmacy
Chemical compound, drug Dexmedetomidine (0.5 mg/kg) University of Rochester Medical Center Pharmacy
Other 3 mm Biopsy punch Integra, Plainsboro, NJ, USA Cat#: 33–32
Other 0.5 mm drill bit FST, Foster City, CA Cat#: 19007–05
Other UV Glue Norland Optical Adhesive, Norland Inc, Cranbury, NJ, USA Cat#: NOA 61
Other Loctite 404 Glue Henkel Corp, Bridgewater, NJ, USA Cat#: A-A-309
Other Headplate Emachine shop Design courtesy of Mriganka Sur
Other C and B Metabond Dental Cement Parkell Inc
Brentwood, NY, USA
SKU #: S380
Other Ti: Sapphire Mai-Tai
Spectraphysics
Olympics, Center Valley, PA
Custom built two photon microscope
Antibody Anti-Iba-1 (Rabbit polyclonal) Wako RRID:AB_839504
Cat # 019–19741
IF(1:1000)
Antibody Anti-GFAP
Glial Fibrillary Acidic Protein (Mouse monoclonal)
Sigma RRID:AB_477010
Cat# G3893
IF(1:500)
Antibody Anti-Galectin3 (Goat polcylonal) R and D systems RRID:AB_2234687
Cat# AF1197
IF(1:1500)
Antibody AlexaFlour 488 (Donkey Anti-Rabbit) Invitrogen RRID:AB_2762833
Cat# A32790
IF(1:500)
Antibody AlexaFlour 594 (Donkey Anti-Mouse) Invitrogen RRID:AB_2762826
Cat# A32744
IF(1:500)
Antibody AlexaFlour 594 (Donkey Anti-Goat) Invitrogen RRID:AB_2762828
Cat# A32758
IF(1:1000)
Commercial assay or kit MILLIPLEX MAP Mouse TH17 Magnetic Bead Panel (Mouse) Millipore, Sigma MTH17MAG-47K
MATLAB MATLAB and Statistics Toolbox Release 2012b, The MathWorks, Inc, Natick, Massachusetts, United States RRID:SCR_001622
GraphPad Prism GraphPad Software, https://www.graphpad.com’. San Diego, California USA, RRID:SCR_002798
R R Project for Statistical Computing RRID:SCR_001905

Experimental animals

All animal works were performed according to the approved guidelines from the University of Rochester, Institutional Animal Care and Use Committee and conformed to the National Institute of Health (NIH). Animals were housed in a 12 hr light/12 hr dark cycle with food ad libitum. Three- to 6-month-old male and female heterozygous (CX3CR1-GFP) (RRID:IMSR_JAX:005582) GFP reporter mice expressing GFP under control of the fractalkine receptor (CX3CR1) promoter (Jung et al., 2000) and P2Y12-KO mice were used for in vivo live imaging of visual cortex microglia repopulation and dynamics. All mice were derived from and maintained on a C57/Bl6 background.

Microglia depletion

Diet (AIN-76A-D1001i, Research Diets, New Jersey, USA) containing 1200 mg/kg PLX5622 (Plexxikon Inc, Berkeley, CA, USA) was given to mice as the sole food source for 1–2 weeks to deplete microglia. Control diet with the same base formula but without the compound was given to the control group (Bl6 mice in Supplementary Figure 1 and 2 that are not exposed to PLX) and during the repopulation phase for 3–4 weeks.

Cranial window surgery

Animals were anesthetized using a fentanyl cocktail (i.p.) during the cranial window implantation surgical procedure. The fentanyl cocktail consisted of fentanyl (0.05 mg kg−1), midazolam (5.0 mg kg−1), and dexmedetomidine (0.5 mg kg−1). Body temperature was maintained at 37°C with a heating pad and aseptic technique was maintained during all surgical procedures. Mice were placed in a stereotaxic frame and head-fixed for cranial window surgeries. Hair was removed and the skull was exposed through a scalp incision. A 3 mm Biopsy punch (Integra, Plainsboro, NJ, USA) was used to create a circular score on the skull over V1. A 0.5 mm drill bit (FST, Foster City, CA) was used to then drill through the skull for the craniotomy, tracing the 3 mm score. A 5 mm coverslip attached to a 3 mm coverslip (Warner Instruments, Harvard Bioscience, Hamden, CT) by UV glue (Norland Optical Adhesive, Norland Inc, Cranbury, NJ, USA) was then slowly lowered down into the craniotomy (3 mm Side down). The coverslip was secured with Loctite 404 glue (Henkel Corp, Bridgewater, NJ, USA). A custom headplate produced by emachine shop (http://www.emachineshop.com) (designs courtesy of the Mriganka Sur Lab, MIT) was kept in place with C and B Metabond Dental cement (Parkell Inc, Brentwood, NY, USA). The dental cement was used to cover exposed skull and keep the headplate in place. Mice were administered slow-release buprenex by veterinary staff (s.q. mg kg-1 every 72 hr) and monitored for 72 hr.

Two-photon microscopy

A custom two-photon laser-scanning microscope was used for in vivo imaging (Ti: Sapphire, Mai-Tai, Spectraphysics; modified Fluoview confocal scan head, 20x water immersion objective lens, 0.95 numerical aperture, Olympus, Center Valley, PA). Excitation for fluorescent imaging was achieved with 100-fs laser pulses (80MHz) tuned to 920 nm for GFP with a power of ~30–40 mW measured at the sample. Fluorescence was detected using a photomultiplier tube in whole-field detection mode using a 580/180 filter. Images were collected from 20 μm to 300 μm into the brain. For repeated imaging, blood vessels were used as gross landmarks and stable microglia were also used as fine landmarks to re-identify the correct region for imaging. Image analysis was done offline using ImageJ and Matlab with custom algorithms as described in Stowell et al., 2019a and available at https://github.com/majewska-lab (Stowell et al., 2019b).

Awake and anesthetized imaging sessions

For awake imaging, mice were trained and habituated to awake imaging during the 2-week recovery from cranial window surgeries. Mice were head fixed under the microscope for 10 min on the first day and the time spent head fixed was increased by 5 min daily. Habituation sessions were terminated if mice exhibited signs of discomfort such as excessive movement and vocalization. Training was complete once mice tolerated 4 consecutive days of head fixation. The imaging session did not exceed 60 min daily. For imaging of microglial morphology and motility, a separate cohort of mice was used and anesthetized using Fentanyl Cocktail. Fentanyl cocktail contained Fentanyl (0.05 mg per kg, intraperitoneally), midazolam (5.0 mg per kg, intraperitoneally), and dexmedetomidine (0.5 m per kg) premixed and given intraperitoneally for each anesthetized imaging session.

Microglia migration analysis

Two-photon XYZ images of microglia were collected. For analysis, microglia within a volume of 800 X 600 X 100 μm (approximately 60 to 160 μm from the surface of the brain) were used. The images were processed and aligned using Fiji ImageJ. The centroid for each microglia was identified and the x, y, and z coordinates were recorded. Images were aligned over consecutive days using the blood vessels as gross landmarks. A custom algorithm was created to quantify the distances between individual microglia and the remaining microglia in the image. The minimum value was then used as the 3D nearest neighbor value for that microglia and nearest neighbor values were averaged together for all microglia in a single animal at each time point.

Distances were calculated as shown below:

distances (i,j)=sqrt(xaxis(i)  xaxis(j))2 + (yaxis(i)yaxis(j))2 + (zaxis(i)zaxis(j))2

i, j corresponds to number of microglia in the matrix used to calculate the NN.

Microglial translocation

The location of selected microglia from the first time point were identified, and the XYZ coordinates for the microglia were recorded for the first day. The 3D Nearest neighbor values were calculated as shown above except the location of a microglia was compared to the location of all microglia at another time point. Usually, translocation was measured relative to Day1 of imaging or the time point immediately prior.

Mathematical modeling of microglial repopulation

We began with three parameters:

  1. N0, the number of cells in the population on day 2 of the daily imaging paradigm,

  2. p, a specified probability that a cell will undergo division,

  3. R, the observed division rates in experimental data.

Using R (RRID:SCR_001905), the algorithm was then initialized with the following values (Figure 5—source code 1). The number of cells chosen to divide from is given by D0 and were selected by sampling from a binomial distribution of size N0 with probability p. Each cell selected for the division was assigned a division rate by generating a sample S0 of size D0 from R. This process was repeated every 4 hr over a 24-hr period (Figure 5—figure supplement 1). We also considered cells to be ineligible for the repeated division for a period of 4 hr after having divided. Using the specified notation and letting i=1,2,3,4,5,6 and tn=4n, we can denote the number of microglia in the population during the ith interval by Ni, where

Ni={N0D0,ifi=1Ni1Di1+2j=0i2k=1DjI(Sjk=ti1j),ifi>1.

The final number of cells counted in the population was given by the sum of cells that have completed division and those that are still undergoing division, expressed by

Nfinal=N6+j=05k=1DjI(Sjk>t5j).

Microglia morphology

For microglial morphology analysis, 2–4 microglia were selected per animal in an imaging session. For each microglia selected, a z-projection was created using FIJI. All microglia processes were manually traced, thresholded to generate a binarized outline of the process arbor, filtered to remove artifacts, and analyzed with an automated Sholl Analysis plugin (provided by the Anirvan Ghosh laboratory, University of California, San Diego). The maximum number of intersections and the area under the curve (AUC) of the Sholl profile was analyzed to determine microglia arbor complexity.

Microglia motility and surveillance

For motility analysis, XYZT images consisting of 40-μm-deep z-stacks were collected every 5 min, 12 times for a total of 60 min. Single-image 10 μm Z-projections were created for each time point, and lateral motion artifact was corrected using the StackReg and TurboReg functions (http://bigwww.epfl.ch/thevenaz/stackreg/). After thresholding and binarizing of the maximum intensity projections for all time points together, overlays of consecutive time points (0–5 min, 5–10 min, etc.) were made, so that white pixels represented stability. A custom Matlab algorithm was used to compare pixels across individual time points and across consecutive time points to generate a motility index (defined as the sum of all changed pixels divided by the unchanged pixels). Additional indices were generated, including stability, as the proportion of extension pixels (green) in one overlay that became stable (white) in the subsequent overlay divided by the total extension (green) pixels in the first overlay. Conversely, an instability index was calculated as the proportion of stable (white) pixels in one overlay that became retracted (magenta) in the subsequent overlay divided by the total stable (white) pixels in the first overlay.

For the surveillance ratio, we z projected all 12-time points and compiled them into a stack. We then aligned the stacks and modulated the brightness/contrast to ensure that all processes were visible, and background was minimal. The z-projected files were then thresholded. The thresholding parameters were chosen to capture most of the processes while minimizing background pixilation. The thresholded time points were used to calculate the area surveyed (surveillance ratio) by microglia during the 1 hr imaging session. This was done by calculating the total number of pixels representing microglia divided by the total pixels in the field of view. This number was further divided by the proportion of pixels representing microglia in the 1st time point to generate the normalized surveillance.

Microglia soma area quantification

Two to 10 microglia were selected at random from high-magnification images. Single-image 10 μm Z-projections were created for each time point, and lateral motion artifact was corrected using the StackReg and TurboReg functions (http://bigwww.epfl.ch/thevenaz/stackreg/). The polygon tool was used to outline the soma of microglia, and the area was calculated in microns (μm).

Laser ablation

Laser ablation injuries were created by running a point scan for 8 s at 780 nm using ~75 mW at the sample. The microglia injury response was imaged by collecting z-stacks of 50–90 μm every 5 min. For analysis, Z-projections were all comprised of 10 μm of the stack, encompassing the approximate center of the ablation core. The file was converted to an AVI and subjected to analysis by a custom MATLAB script designed to calculate the movement of microglial processes towards the ablation core. Briefly, for each pixel at each time point, the script generates a vector that estimates the magnitude and direction of motion of the pixel utilizing the Farneback method for estimating optic flow. For analysis, we only included vectors larger than 5 pixels of motion, which were directed toward the ablation core to minimize noise. The magnitude of all the vectors at each time point was summed and normalized to the total number of pixels in the image. For the convergence analysis, the number of pixels that enter the core of the focal injury was summed. We quantified the area under the curve and the maximum value of the normalized magnitude over the 1 hr session.

Histology

Whole brains were perfused with 0.1M PBS and fixed overnight with paraformaldehyde (4%). The tissue was cut on a freezing microtome (Microm; Global Medical Instrumentation) at 50 μm. For immunohistochemistry, sections were rinsed, and endogenous peroxidase activity and nonspecific binding were blocked with a 10% BSA solution. Sections were then incubated in primary antibody solution to detect microglia (24 hr, 4°C, anti-Iba-1, 1:1,000, Wako 019–19741) followed by a secondary antibody solution (4 hr, RT, AlexaFluor 488, 1:500, Invitrogen), mounted and coverslipped. To determine microglial depletion and repopulation, primary visual cortex sections were imaged on a Zeiss LSM 510 confocal microscope (Carl Zeiss). For each section, a 10 mm z stack in the center of the tissue was collected with a z step of 1 µm at ×40 magnification. The analysis was performed offline in ImageJ. Z stacks were smoothed and compressed into a single z projection. Microglial cell bodies were marked in ImageJ using the paintbrush tool. Results from four to five sections per animal were averaged. Density was calculated as the number of microglia per area in the visual cortex for PLX depleted and control groups.

For the quantification of astrocytes, tissue was processed for histology as described above. Sections were incubated in a primary antibody solution (overnight, 4°C, Anti-Glial Fibrillary Acidic Protein (GFAP), 1:500, Sigma G3893, clone G-A-5) followed by a secondary antibody solution (4 hr, RT, AlexaFluor 594, 1:500, Invitrogen), mounted and coverslipped. To determine astrocyte coverage, somatosensory cortex sections were imaged on a Zeiss LSM 510 confocal microscope (Carl Zeiss). For each section, a 10 µm z stack in the center of the tissue was collected with a z step of 1 µm at ×40 magnification. The analysis was performed offline in ImageJ. The images were thresholded, and the total number of white pixels were then measured. Results from three to four sections per animal were averaged.

Immunohistochemical assessment of repopulated microglia was carried out in brains of CX3CR1-GFP animals received control chow for 2.5 days after 7 day PLX5562 or control that were never exposed to PLX (n=four for each treatment, mixed sex). Tissue was processed for histology in similar manner as described above. Sections were incubated in goat-anti-Galectin 3 (1:1500, R and D Systems AF1197) at 4°C overnight, then washed and incubated in AlexaFluor 594 (1:1000, Invitrogen) secondary at RT, subsequently mounted and coverslipped. Consistent with our in vivo imaging, primary visual cortex sections were imaged (three sections/animal) on a Nikon AR1 HD laser scanning confocal microscope (Nikon). Two or three non-overlapping images were collected per V1; using a 40X water-submersion objective lens and imaged at 0.5 µm z-step using the same laser setting across all sections. Analysis was performed using ImageJ, and statistical analysis was completed in R (R Core Team 2021). For image analysis, the intensity of Galectin-3 was measured in doublets, singlets, and control microglia separately. In addition, microglial soma morphology was also assessed using several parameters: perimeter, area, long axis, and short-axis as well as elongation (long/short axis ratio). Data were processed in R and plotted using Prism (GraphPad).

Immunoassay

CX3CR1-GFP mice (n=seven for each treatment, mixed-sex) were fed PLX5622 chow or control chow for seven consecutive days. On the 7th day, mice were sacrificed using Euthasol (1:10 dilution) and perfused with 0.15M PBS containing 0.5% sodium nitrite (weight/volume) and 2 I.U. heparin/mL. Cortices were dissected from one hemisphere then immediately frozen in ice-cold isopentane. Frozen cortices were weighed and homogenized in T-PER (pH=7.6, 25 µL/mg, Thermo Fisher) for 30 s, vortexed, and subsequently sonicated for an additional 30 s. Cortical lysates were centrifuged for 5 min at 14,000 g twice; each time, clarified supernatants were saved, and the pellets were discarded. Concentrations of inflammatory modulators in homogenates were measured using MILLIPLEX MAP Mouse TH17 Magnetic Bead Panel (Millipore, Sigma) as per manufacture recommendations. The following cytokines were assessed: IL-1β, IL-4, IL-6, IL-10, TNFα. For all cytokines, a 5-Parameter logistic model was used to fit the standard curves for absorbance values.

Statistics

Statistical comparisons were made between animal and treatment groups using Prism eight software (GraphPad, San Diego, CA). Samples sizes are similar to those reported in the field and were based on previous experiments. All n represents individual animals. Exclusion criteria were discussed prior to analysis and included (1) poor image quality (either due to excessive movement artifact or low signal to noise) as determined qualitatively prior to quantification; (2) the health of the animal (defined as hunched posture and limited movement) as observed during imaging; (3) incomplete imaging sessions. All microglia analyzed in each animal were averaged to generate a single value per animal. Because not all animals could be imaged at all time points, we used a one-way ANOVA and treated each measurement at different time points as independent, which was supported by the examination of residuals. All values reported are the mean ± s.e.m. For all analyses, α = 0.05. Two-tailed unpaired or paired t-tests and one-way or two-way ANOVA with or without repeated measures (ANOVA) with Tukey post hoc comparisons were used to compare cohorts where appropriate. The exact p values are provided in a supplementary file. The data met the assumptions of normality and equal variances as tested by Prism eight as part of the statistical analyses.

Acknowledgements

We thank J Olschowka and K O’Banion for sharing PCR resources. We thank the Ghosh laboratory for the Sholl Analysis Fiji plugin. This work is supported by grants from the National Institute of Health (NIH): F99 NS108486-02 (MSM), R01 EY019277, RO1 NS114480 and R21 NS099973 (AKM), and NSF 1557971 (AKM). We thank Plexxikon for providing PLX5622.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Ania K Majewska, Email: ania_majewska@urmc.rochester.edu.

Sonia Garel, Ecole Normale Superieure, France.

Satyajit Rath, Indian Institute of Science Education and Research (IISER), India.

Funding Information

This paper was supported by the following grants:

  • NIH Blueprint for Neuroscience Research F99 NS108486-02 to Monique S Mendes.

  • National Institute of Neurological Disorders and Stroke R01 EY019277 to Ania K Majewska.

  • National Institute of Neurological Disorders and Stroke RO1 NS114480 to Ania K Majewska.

  • National Institute of Neurological Disorders and Stroke R21 NS099973 to Ania K Majewska.

  • National Science Foundation 1557971 to Ania K Majewska.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing.

Data curation, Formal analysis, Methodology, Writing - review and editing.

Data curation, Formal analysis, Writing - review and editing.

Formal analysis, Methodology, Writing - review and editing.

Formal analysis.

Formal analysis.

Formal analysis.

Formal analysis, Methodology, Writing - review and editing.

Conceptualization, Resources, Supervision, Funding acquisition, Validation, Writing - original draft, Writing - review and editing.

Ethics

Animal Experiments: All animal work was performed according to the approved guidelines from the University of Rochester, Institutional Animal Care and Use Committee and conformed to the National Institute of Health (NIH). Animals were housed in a 12-hour light/12-hour dark cycle with food ad libitum. Mice were housed in cages on a standard 12:12 hour light/dark cycle with food and water ad libitum. All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Ethical approval number: UCAR: 2008-111; expires Dec. 1, 2023.

Additional files

Transparent reporting form

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.All MATLAB codes are available at https://github.com/majewska-lab.

References

  1. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature Neuroscience. 2007;10:1538–1543. doi: 10.1038/nn2014. [DOI] [PubMed] [Google Scholar]
  2. Askew K, Li K, Olmos-Alonso A, Garcia-Moreno F, Liang Y, Richardson P, Tipton T, Chapman MA, Riecken K, Beccari S, Sierra A, Molnár Z, Cragg MS, Garaschuk O, Perry VH, Gomez-Nicola D. Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain. Cell Reports. 2017;18:391–405. doi: 10.1016/j.celrep.2016.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ayata P, Badimon A, Strasburger HJ, Duff MK, Montgomery SE, Loh YE, Ebert A, Pimenova AA, Ramirez BR, Chan AT, Sullivan JM, Purushothaman I, Scarpa JR, Goate AM, Busslinger M, Shen L, Losic B, Schaefer A. Epigenetic regulation of brain region-specific microglia clearance activity. Nature Neuroscience. 2018;21:1049–1060. doi: 10.1038/s41593-018-0192-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, Weissman IL, Chang EF, Li G, Grant GA, Hayden Gephart MG, Barres BA. New tools for studying microglia in the mouse and human CNS. PNAS. 2016;113:E1738–E1746. doi: 10.1073/pnas.1525528113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bruttger J, Karram K, Wörtge S, Regen T, Marini F, Hoppmann N, Klein M, Blank T, Yona S, Wolf Y, Mack M, Pinteaux E, Müller W, Zipp F, Binder H, Bopp T, Prinz M, Jung S, Waisman A. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. Immunity. 2015;43:92–106. doi: 10.1016/j.immuni.2015.06.012. [DOI] [PubMed] [Google Scholar]
  6. Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, Nishinakamura R, Becher B, Greter M. Sall1 is a transcriptional regulator defining microglia identity and function. Nature Immunology. 2016;17:1397–1406. doi: 10.1038/ni.3585. [DOI] [PubMed] [Google Scholar]
  7. Crotti A, Ransohoff RM, Physiology M. Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling. Immunity. 2016;44:505–515. doi: 10.1016/j.immuni.2016.02.013. [DOI] [PubMed] [Google Scholar]
  8. Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R, West BL, Green KN. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. Journal of Neuroinflammation. 2015;12:139. doi: 10.1186/s12974-015-0366-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Biase LM, Schuebel KE, Fusfeld ZH, Jair K, Hawes IA, Cimbro R, Zhang HY, Liu QR, Shen H, Xi ZX, Goldman D, Bonci A. Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia. Neuron. 2017;95:341–356. doi: 10.1016/j.neuron.2017.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380–397. doi: 10.1016/j.neuron.2014.02.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elmore MR, Lee RJ, West BL, Green KN. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation. PLOS ONE. 2015;10:e0122912. doi: 10.1371/journal.pone.0122912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Elmore MRP, Hohsfield LA, Kramár EA, Soreq L, Lee RJ, Pham ST, Najafi AR, Spangenberg EE, Wood MA, West BL, Green KN. Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice. Aging Cell. 2018;17:e12832. doi: 10.1111/acel.12832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eyo UB, Peng J, Swiatkowski P, Mukherjee A, Bispo A, Wu L-J. Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. Journal of Neuroscience. 2014;34:10528–10540. doi: 10.1523/JNEUROSCI.0416-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eyo UB, Mo M, Yi MH, Murugan M, Liu J, Yarlagadda R, Margolis DJ, Xu P, Wu LJ. P2Y12R-Dependent Translocation Mechanisms Gate the Changing Microglial Landscape. Cell Reports. 2018;23:959–966. doi: 10.1016/j.celrep.2018.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Füger P, Hefendehl JK, Veeraraghavalu K, Wendeln AC, Schlosser C, Obermüller U, Wegenast-Braun BM, Neher JJ, Martus P, Kohsaka S, Thunemann M, Feil R, Sisodia SS, Skodras A, Jucker M. Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging. Nature Neuroscience. 2017;20:1371–1376. doi: 10.1038/nn.4631. [DOI] [PubMed] [Google Scholar]
  16. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–845. doi: 10.1126/science.1194637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ginhoux F, Lim S, Hoeffel G, Low D, Huber T. Origin and differentiation of microglia. Frontiers in Cellular Neuroscience. 2013;7:45. doi: 10.3389/fncel.2013.00045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh J, Marsh SE, Saunders A, Macosko E, Ginhoux F, Chen J, Franklin RJM, Piao X, McCarroll SA, Stevens B. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50:253–271. doi: 10.1016/j.immuni.2018.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg EC, Tanaka M, van Rooijen N, García-Sastre A, Stanley ER, Ginhoux F, Frenette PS, Merad M. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792–804. doi: 10.1016/j.immuni.2013.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nature Neuroscience. 2006;9:1512–1519. doi: 10.1038/nn1805. [DOI] [PubMed] [Google Scholar]
  21. Hefendehl JK, Neher JJ, Sühs RB, Kohsaka S, Skodras A, Jucker M. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell. 2014;13:60–69. doi: 10.1111/acel.12149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoeffel G, Chen J, Lavin Y, Low D, Almeida FF, See P, Beaudin AE, Lum J, Low I, Forsberg EC, Poidinger M, Zolezzi F, Larbi A, Ng LG, Chan JK, Greter M, Becher B, Samokhvalov IM, Merad M, Ginhoux F. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity. 2015;42:665–678. doi: 10.1016/j.immuni.2015.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Huang Y, Xu Z, Xiong S, Qin G, Sun F, Yang J, Yuan TF, Zhao L, Wang K, Liang YX, Fu L, Wu T, So KF, Rao Y, Peng B. Dual extra-retinal origins of microglia in the model of retinal microglia repopulation. Cell Discovery. 2018a;4:9. doi: 10.1038/s41421-018-0011-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Huang Y, Xu Z, Xiong S, Sun F, Qin G, Hu G, Wang J, Zhao L, Liang YX, Wu T, Lu Z, Humayun MS, So KF, Pan Y, Li N, Yuan TF, Rao Y, Peng B. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nature Neuroscience. 2018b;21:530–540. doi: 10.1038/s41593-018-0090-8. [DOI] [PubMed] [Google Scholar]
  25. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Molecular and Cellular Biology. 2000;20:4106–4114. doi: 10.1128/MCB.20.11.4106-4114.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017;169:1276–1290. doi: 10.1016/j.cell.2017.05.018. [DOI] [PubMed] [Google Scholar]
  27. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Hölscher C, Müller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nature Neuroscience. 2013;16:273–280. doi: 10.1038/nn.3318. [DOI] [PubMed] [Google Scholar]
  28. Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E, Xu Y, Fanek Z, Greco DJ, Smith ST, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich JD, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner FL, Litvak V, Holtzman DM, Lassmann H, Weiner HL, Ochando J, Haass C, Butovsky O. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566–581. doi: 10.1016/j.immuni.2017.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Li Y, Du XF, Liu CS, Wen ZL, Du JL. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Developmental Cell. 2012;23:1189–1202. doi: 10.1016/j.devcel.2012.10.027. [DOI] [PubMed] [Google Scholar]
  30. Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, Okamoto J, Gulati G, Bennett ML, Sun LO, Clarke LE, Marschallinger J, Yu G, Quake SR, Wyss-Coray T, Barres BA. Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019;101:207–223. doi: 10.1016/j.neuron.2018.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Liu Y. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. bioRxiv. 2019 doi: 10.1101/557686. [DOI] [PMC free article] [PubMed]
  32. Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, Ben-Yehuda H, David E, Zelada González F, Perrin P, Keren-Shaul H, Gury M, Lara-Astaiso D, Thaiss CA, Cohen M, Bahar Halpern K, Baruch K, Deczkowska A, Lorenzo-Vivas E, Itzkovitz S, Elinav E, Sieweke MH, Schwartz M, Amit I. Microglia development follows a stepwise program to regulate brain homeostasis. Science. 2016;353:aad8670. doi: 10.1126/science.aad8670. [DOI] [PubMed] [Google Scholar]
  33. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Brück W, Priller J, Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nature Neuroscience. 2007;10:1544–1553. doi: 10.1038/nn2015. [DOI] [PubMed] [Google Scholar]
  34. Najafi AR, Crapser J, Jiang S, Ng W, Mortazavi A, West BL, Green KN. A limited capacity for microglial repopulation in the adult brain. Glia. 2018;66:2385–2396. doi: 10.1002/glia.23477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–1318. doi: 10.1126/science.1110647. [DOI] [PubMed] [Google Scholar]
  36. O'Koren EG, Yu C, Klingeborn M, Wong AYW, Prigge CL, Mathew R, Kalnitsky J, Msallam RA, Silvin A, Kay JN, Bowes Rickman C, Arshavsky VY, Ginhoux F, Merad M, Saban DR. Microglial Function Is Distinct in Different Anatomical Locations during Retinal Homeostasis and Degeneration. Immunity. 2019;50:723–737. doi: 10.1016/j.immuni.2019.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Orłowski D, Sołtys Z, Janeczko K. Morphological development of microglia in the postnatal rat brain A quantitative study. International journal of developmental neuroscience. 2003;21:445–450. doi: 10.1016/j.ijdevneu.2003.09.001. [DOI] [PubMed] [Google Scholar]
  38. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nature Reviews Neurology. 2010;6:193–201. doi: 10.1038/nrneurol.2010.17. [DOI] [PubMed] [Google Scholar]
  39. Réu P, Khosravi A, Bernard S, Mold JE, Salehpour M, Alkass K, Perl S, Tisdale J, Possnert G, Druid H, Frisén J. The Lifespan and Turnover of Microglia in the Human Brain. Cell Reports. 2017;20:779–784. doi: 10.1016/j.celrep.2017.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rice RA, Spangenberg EE, Yamate-Morgan H, Lee RJ, Arora RP, Hernandez MX, Tenner AJ, West BL, Green KN. Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus. Journal of Neuroscience. 2015;35:9977–9989. doi: 10.1523/JNEUROSCI.0336-15.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sipe GO, Lowery RL, Tremblay MÈ, Kelly EA, Lamantia CE, Majewska AK. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nature Communications. 2016;7:10905. doi: 10.1038/ncomms10905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Smith KL, Kassem MS, Clarke DJ, Kuligowski MP, Bedoya-Pérez MA, Todd SM, Lagopoulos J, Bennett MR, Arnold JC. Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD. Brain, Behavior, and Immunity. 2019;80:889–899. doi: 10.1016/j.bbi.2019.05.042. [DOI] [PubMed] [Google Scholar]
  43. Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 2016;139:1265–1281. doi: 10.1093/brain/aww016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stowell RD, Sipe GO, Dawes RP, Batchelor HN, Lordy KA, Whitelaw BS, Stoessel MB, Bidlack JM, Brown E, Sur M, Majewska AK. Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nature Neuroscience. 2019a;22:1782–1792. doi: 10.1038/s41593-019-0514-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stowell R, Sipe GO, Dawes RP, Batchelor HN, Lordy KA, Bidlack JM, Brown E, Sur M, Majewska AK. Stowell_2019_NatNeuro. 940efe4GitHub . 2019b https://github.com/majewska-lab/Stowell_2019_NatNeuro
  46. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Progress in Neurobiology. 1999;57:563–581. doi: 10.1016/S0301-0082(98)00069-0. [DOI] [PubMed] [Google Scholar]
  47. Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. Journal of Neuroinflammation. 2004;1:14. doi: 10.1186/1742-2094-1-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sun W, Suzuki K, Toptunov D, Stoyanov S, Yuzaki M, Khiroug L, Dityatev A. In vivo Two-Photon Imaging of Anesthesia-Specific Alterations in Microglial Surveillance and Photodamage-Directed Motility in Mouse Cortex. Frontiers in Neuroscience. 2019;13:421. doi: 10.3389/fnins.2019.00421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tay TL, Mai D, Dautzenberg J, Fernández-Klett F, Lin G, Sagar, Datta M, Drougard A, Stempfl T, Ardura-Fabregat A, Staszewski O, Margineanu A, Sporbert A, Steinmetz LM, Pospisilik JA, Jung S, Priller J, Grün D, Ronneberger O, Prinz M. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nature Neuroscience. 2017;20:793–803. doi: 10.1038/nn.4547. [DOI] [PubMed] [Google Scholar]
  50. Zhan L, Krabbe G, Du F, Jones I, Reichert MC, Telpoukhovskaia M, Kodama L, Wang C, Cho SH, Sayed F, Li Y, Le D, Zhou Y, Shen Y, West B, Gan L. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLOS Biology. 2019;17:e3000134. doi: 10.1371/journal.pbio.3000134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zhan L, Fan L, Kodama L, Sohn PD, Wong MY, Mousa GA, Zhou Y, Li Y, Gan L. A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain. eLife. 2020;9:e51796. doi: 10.7554/eLife.51796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zhang Y, Zhao L, Wang X, Ma W, Lazere A, Qian H, Zhang J, Abu-Asab M, Fariss RN, Roger JE, Wong WT. Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation. Science Advances. 2018;4:eaap8492. doi: 10.1126/sciadv.aap8492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: Sonia Garel1
Reviewed by: Amanda Sierra2

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

All reviewers highlighted the interest of your study that provides an elegant longitudinal study and mathematical modeling of microglial self-renewal and maturation. Your response and revised manuscript fully answers the reviewers comments on the mathematical model, the statistical analyses of doublets as well as a more in depth description of the PLX diet model. Taken together, your findings elegantly describe a novel dynamics of microglial self-renewal and maturation and the role of a key pathway in this process.

Decision letter after peer review:

Thank you for submitting your article "P2Y12 is not a major regulator of the kinetics of microglial self-renewal and maturation in the adult visual cortex" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Amanda Sierra (Reviewer #1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is "in revision at eLife". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

All reviewers highlighted the interest of your study that provides an elegant longitudinal study and mathematical modeling of microglial self-renewal and maturation. However, they also raised specific major and major points that should be addressed in a revised version of the manuscript. In particular, they stressed the importance to provide:

i) A clearer description of the mathematical model;

ii) A clarification of the notion of doublets, their statistical analyses as well as an in vivo evidence that they correspond to cell division;

iii) Stronger statistical analyses of the changes in cytokines after PLX diet and of the impact of P2Y12 inactivation on microglial morphology.

We look forward to receiving a revised version of your manuscript and thank you for considering eLife.

Reviewer #1:

The manuscript "P2Y12 is not a major regulator of the microglial self-renewal and maturation in the adult visual cortex" by Mendes et al. is an elegantly written manuscript that shows very solid data on the kinetics of microglial self-renewal and acquisition of functional maturation after depletion with one of the most promising therapeutic tools in neurodegenerative diseases, the CSf1 inhibitor PLX5266. The authors also show that this process is largely independent of P2Y12, a receptor that has been claimed essential to maintain microglial homeostasis.

The data presented is novel, the methods of analysis are the state-of-the-art and several new tools, including a mathematical model have been developed. There are however, a few issues that need to be addressed by the authors.

1. The mathematical model, while very interesting, is very poorly described for a lay audience. As an author of papers that include mathematical models, I am well aware that this is extremely difficult, but the authors need to be clearer both in the methods and in the Results sections.

In the methods, the authors need to describe the rationale for the different formulas proposed to analyze the dynamics of microglia, and the previous references in which their analysis was surely based.

In the results, the authors need also to be more specific (without entering the formula details). I would suggest 1, the draw a cartoon that summarizes how the model was created; 2, create a table where the values used to create the model (both experimental and simulated); and 3, be more specific about the actual comparison between experimental and simulated data. For instance, I have trouble understanding what the "empirical division rates" are (and how are they calculated), as they first appear in line 353 but they were not mentioned earlier.

2. The authors claim that they did not observe changes in cytokine production after 7 days of the PLX diet, but this is due to the low n of their sampling and the large variability (ouliers?) in the PLX group, as in fact strong tendencies can be observed in most cytokines analyzed in Supp. Figure 2. The authors should perform power analysis to determine the n-size, and reach that n if it is feasible. At the very least, they should be more cautious describing their results and concluding a lack of inflammatory response (line 182).

3. While I agree that visually the P2Y12 KO mice data looks largely like the control mouse data throughout the paper, it is unclear whether in all experiments a proper statistical analysis comparing control and KO mice was performed. For instance, data in Figure 2B vs 2D, 2C vs 2E, 5B vs 5G, and all Figure 6 (D vs G, E vs H, F vs I, K vs M, L vs N).

Certainly, showing each set of data in separate graphs (as is done in most of the paper), does not allow a direct comparison. I understand this is done due to the complexity of the data, but the readers should be better informed on the test that was used to analyze the data.

All figures should include more information on the test used, even when the comparison was not significant.

4. Definition of a doublet: as doublets are a critical point to analyze microglial dynamics in this paper ("The characteristic morphologies of microglia in the process of division allowed us to identify "potential" proliferating cells, which we refer to as doublet somas" (line 269)), the authors should be more precise in their description. Are they simply enlarged microglial cell bodies? How large? In figure 2, their identification would be easier for the reader if the contours of what the authors consider to be the cell bodies are drawn.

Similarly, how can the authors be sure microglia in Figure 3 is a multinucleated body (line 239, pointed with an arrow on the figure), if a nuclei staining was not performed? In this particular cell, the authors claim that it did not divide, but at day 4 there is something that looks like another cell right on top – can the authors confirm this?

5. The authors made some interesting observations on the mode of proliferation of microglia that should be quantified to support their conclusions:

– "The appearance of new cells was associated with a characteristic increase and elongation of the cell soma" (line 257).

– "The original microglia often had extensive processes which were maintained during the division and generation of a new microglia" (line 259).

– "newly generated microglia frequently had a ramified microglia arbor on the same day that division was complete" (line 261).

– "newly generated microglia frequently had a ramified microglia arbor on the same day that division was complete. In many cases, we observed that newly born microglia had a long terminal process extending" (line 263) (this is unclear to me from the image.

– "While one microglia cell remained stable within the network of cells and persisted at the imaged position over time, the other microglia moved away and took up new territory adjacent to the parent cell (line 265)".

The frequency of these events should be quantified.

6. In the discussion, the comparison between the maturation of microglia during development and the maturation of microglia observed in this paper is kind of confusing, mostly because most developmental analysis has been done at the transcriptional level (using scRNAseq), whereas this paper is solely based on imaging. I agree that performing scRNAseq is out of the scope of this paper, but the authors should be more precise in their comparison.

An example of this mix up is the sentence "While microglial expression in the early phase of development appears to recapitulate developmental programs (19), we did not observe the typical morphologies of developing microglia, or changes in process dynamics and responses to injury that could indicate a less mature phenotype." (line 591).

Also, what are the "typical morphologies of developing microglia"? and what is known about the motility of developing microglia?

Finally, the use of the word "profile" (line 593) is confusing, because it is usually related to the "transcriptional profile" but the authors seem to use it to refer to their own morphological results.

7. The paper on Mac2+ (possible) microglia progenitors, which is widely discussed in this paper, has not been peer-reviewed and I am unsure about the policies of eLife of citing papers from open repositories such as biorxiv.

Reviewer #2:

In this manuscript, the authors have studied the behavior of microglial self-renewal upon PLX-induced depletion. They first performed in vivo imaging in head-fixed animal and thereby confirmed (ref 6 and 9) that microglia displayed limited migration and turnover. Then, they analyzed the dynamics of repopulation after PLX-induced depletion. They confirmed (ref. 18) that the rapid replenishment observed after depletion is only due to residual microglia, and they propose a mathematical model to support this observation. The authors then show that new-born microglia display a ramified morphology, and a dynamic behavior that is comparable to the one observed before depletion. Finally, the authors show that the parameters of replenishment are not altered by the loss of function of P2Y12R.

A major concern is that most of the data in this manuscript simply confirmed already published experiments. This manuscript also provides new data related to brain replenishment after PLX-induced depletion of microglia. These data will certainly be of great interest for those working in the field of microglia function in the adult, but may have a limited impact outside of this community.

Reviewer #3:

This is an interesting study on microglia self-renewal and maturation in the adult cortex after microglia depletion. The aims are to understand the mechanisms explaining the rapid repopulation and to test whether new microglia are identical to those which have been depleted. There have already been several studies on this subject. The interest of this new study lies in the fact that the authors performed a longitudinal (over 30 days) analysis of microglia dynamics in awake mice.

The results suggest that the rapid population is based on the local proliferation of microglia that escaped depletion and that the new microglia rapidly acquire functional properties typical of adult microglia. The dynamics of this repopulation is largely independent of P2Y12 receptors.

1. An important part of the article is based on the analysis of microglia called "doublet", which would be microglia in the process of proliferation. However, the authors do not provide a very clear definition of what a doublet is and how these doublets were identified. Clearly defined quantitative criteria would make this part more convincing. In addition, as a certain number of these doublets remain in the doublet state, without dividing, during the observation period (up to 30 days), it would be interesting to show that they indeed correspond to cells in the process of proliferation. A correlation between the identification of doublets in vivo and histochemical analysis of nuclear markers after fixation could help.

2. The approach consisting in using the values of the repopulation dynamics obtained with monitoring microglia every 4 hours for 24 hours in a mathematical model (Figure 4) to test whether proliferation alone can explain the observations made with a monitoring less frequent (1 / day) but longer (30 days) (Figure 2) is interesting. Unfortunately, the description of the mathematical modeling is unclear and it is difficult as it is to understand if the results of this modeling actually support the authors' conclusion that "it is reasonable to believe that the repopulation.… came purely from local doublet cell division" (page 16).

3. The authors tend to minimize the role of P2Y12. It is true that this receptor does not modify the dynamics of microglia repopulation. However, after repopulation the morphology of P2Y12 KO microglia is very different from that of wild type microglia. Suppl. Figure 4 clearly shows that at the end of repopulation (D30), P2Y12 KO microglia look more like the control, wild type and P2Y12 KO, microglia than do repopulating wild type microglia. Maybe this could be stressed a bit more clearly as this may be important for microglia-neuron interactions. As for wild type microglia (Figure 5A), pictures of P2Y12 KO microglia in control and at different stages of the repopulation should be shown.

eLife. 2021 Jul 12;10:e61173. doi: 10.7554/eLife.61173.sa2

Author response


All reviewers highlighted the interest of your study that provides an elegant longitudinal study and mathematical modeling of microglial self-renewal and maturation. However, they also raised specific major and major points that should be addressed in a revised version of the manuscript. In particular, they stressed the importance to provide:

i) A clearer description of the mathematical model;

To address the comments on the mathematical model in the manuscript, we included a schematic and more clarification on the description of the model in the text accompanying figure 4 and supplementary figure 7.

ii) A clarification of the notion of doublets, their statistical analyses as well as an in vivo evidence that they correspond to cell division;

To address this comment, we quantified the morphology of doublets on a set of confocal images from fixed brains of control animals and animals that were treated with PLX and allowed to repopulate for 2 days (this is peak repopulation time with a large number of doublet somas present) to determine quantitatively the morphological characteristics that separated singlets from doublets. The somata of doublet cells in repopulated animals were enlarged and irregular in size. While no single morphological measurement (soma area, perimeter, elongation; Figure 3) fully separated doublet and singlet somas, a combination of soma size and perimeter separates out the doublet population from non-doublet microglia in repopulated animals, and from microglia in control animals (Figure 3). Doublets are therefore defined as cells with large somas which are elongated, often to form an irregular soma shape. We also immunoreacted these sections and find an upregulation of Galectin-3 in repopulating microglia, although both doublet and singlet microglia showed high levels of expression (Suppl. Figure 6), consistent with results on proliferation and Galectin-3 expression in Zhan et al., 2020.

iii) Stronger statistical analyses of the changes in cytokines after PLX diet and of the impact of P2Y12 inactivation on microglial morphology.

Cytokine analysis: Based on the data presented in old Suppl. Figure 2, we performed a power analysis and determined that a sample size of 7 animals per group allows us to detect a 2-fold increase in cytokine production with a power of 0.8. We then repeated this experiment with a new cohort of animals and present the data in new Suppl. Figure 2. No significant upregulation of any of the cytokines tested was apparent after PLX treatment. P2Y12 comparisons: We now provide the comparisons between P2Y12KO and CX3Cr1GFP/+ animals in supplementary figures 4-5,9-13.

Reviewer #1:

[…] 1. The mathematical model, while very interesting, is very poorly described for a lay audience. As an author of papers that include mathematical models, I am well aware that this is extremely difficult, but the authors need to be clearer both in the methods and in the Results sections.

In the methods, the authors need to describe the rationale for the different formulas proposed to analyze the dynamics of microglia, and the previous references in which their analysis was surely based.

In the results, the authors need also to be more specific (without entering the formula details). I would suggest 1, the draw a cartoon that summarizes how the model was created; 2, create a table where the values used to create the model (both experimental and simulated); and 3, be more specific about the actual comparison between experimental and simulated data. For instance, I have trouble understanding what the "empirical division rates" are (and how are they calculated), as they first appear in line 353 but they were not mentioned earlier.

We included a schematic that describes the mathematical model in its entirety as supplementary figure 7. In addition, we expanded on the mathematical model in the Results section that accompanies figure 4. We also included a detailed description of the formula used for the model which was created specifically for this analysis by Dr. Matthew McCall and Zachary Brehm, both co-authors on the manuscript.

2. The authors claim that they did not observe changes in cytokine production after 7 days of the PLX diet, but this is due to the low n of their sampling and the large variability (ouliers?) in the PLX group, as in fact strong tendencies can be observed in most cytokines analyzed in Supp. Figure 2. The authors should perform power analysis to determine the n-size, and reach that n if it is feasible. At the very least, they should be more cautious describing their results and concluding a lack of inflammatory response (line 182).

To address this question, we performed a power analysis in consultation with Dr. Matthew McCall. We found that 7 animals for each group (control versus PLX) were necessary to achieve a power of 0.8 to detect a 2-fold change in cytokine release. We decided on a conservative 2-fold changes although most papers using inflammatory stimuli show upregulations of cytokines that are at least several fold and in some cases an order of magnitude. Using a new cohort of animals, we investigated how PLX treatment affected IL-1b, IL-4, IL-6, IL-10 and TNF-a and found that there was no observed change in the cytokine production after PLX (supplementary figure 2). This is in line with previously published work using PLX5622.

3. While I agree that visually the P2Y12 KO mice data looks largely like the control mouse data throughout the paper, it is unclear whether in all experiments a proper statistical analysis comparing control and KO mice was performed. For instance, data in Figure 2B vs 2D, 2C vs 2E, 5B vs 5G, and all Figure 6 (D vs G, E vs H, F vs I, K vs M, L vs N).

Certainly, showing each set of data in separate graphs (as is done in most of the paper), does not allow a direct comparison. I understand this is done due to the complexity of the data, but the readers should be better informed on the test that was used to analyze the data.

All figures should include more information on the test used, even when the comparison was not significant.

We provided the comparisons between P2Y12KO and CX3Cr1GFP/+ animals in supplementary figures 4-5,9-13.

4. Definition of a doublet: as doublets are a critical point to analyze microglial dynamics in this paper ("The characteristic morphologies of microglia in the process of division allowed us to identify "potential" proliferating cells, which we refer to as doublet somas" (line 269)), the authors should be more precise in their description. Are they simply enlarged microglial cell bodies? How large? In figure 2, their identification would be easier for the reader if the contours of what the authors consider to be the cell bodies are drawn.

To address this comment, we quantified the morphology of doublets on a set of confocal images from fixed brains of control animals and animals that were treated with PLX and allowed to repopulate for 2 days (this is peak repopulation time with a large number of doublet somas present) to determine the morphological characteristics that separated singlets from doublets. The somata of doublet cells in repopulated animals were enlarged and irregular in size. While no single morphological measurement (soma area, perimeter, elongation; Figure 3) fully separated doublet and singlet somas, a combination of soma size and perimeter largely separates out the doublet population from non-doublet microglia in repopulated animals, and from microglia in control animals (Figure 3). Doublets are therefore defined as cells with large somas (generally over 100um2 in cross section, compared to an average of 75um2 for control cells) which are elongated, often to form an irregular soma shape.

Similarly, how can the authors be sure microglia in Figure 3 is a multinucleated body (line 239, pointed with an arrow on the figure), if a nuclei staining was not performed? In this particular cell, the authors claim that it did not divide, but at day 4 there is something that looks like another cell right on top – can the authors confirm this?

We only observed a large mass of microglia that may represent a multinucleated body once in all our imaging sessions and thus were not able to analyze this phenomenon. While multinucleated bodies have been observed in the Bruttger et al., 2015 paper, we do not believe they contribute to microglial proliferation after depletion with PLX5662.

5. The authors made some interesting observations on the mode of proliferation of microglia that should be quantified to support their conclusions:

We quantified these observations in a subset of doublets (22 from 3 animals) that could be clearly followed across imaging time points with high spatial and temporal resolution (from the imaging interval of 4 hours shown in Figure 4).

– "The appearance of new cells was associated with a characteristic increase and elongation of the cell soma" (line 257).

91% of new cells were associated with a characteristic increase and elongation of the cell soma of the original cell.

– "The original microglia often had extensive processes which were maintained during the division and generation of a new microglia" (line 259).

95% of the original microglia had extensive process which were maintained during the division and generation of a new microglia.

– "newly generated microglia frequently had a ramified microglia arbor on the same day that division was complete" (line 261).

82% newly-generated microglia had a ramified microglia arbor on the same day that division was complete.

– "newly generated microglia frequently had a ramified microglia arbor on the same day that division was complete. In many cases, we observed that newly born microglia had a long terminal process extending" (line 263) (this is unclear to me from the image.

We removed this observation as we found it difficult to provide an objective definition of this phenomenon.

– "While one microglia cell remained stable within the network of cells and persisted at the imaged position over time, the other microglia moved away and took up new territory adjacent to the parent cell (line 265)".

We modified the language of this in the text to reflect that it is difficult to identify and differentiate between parent cells and new cells.

This data was included in the text in the Section “Residual microglia are capable of rapid division to generate new microglia and repopulate the cortex”.

6. In the discussion, the comparison between the maturation of microglia during development and the maturation of microglia observed in this paper is kind of confusing, mostly because most developmental analysis has been done at the transcriptional level (using scRNAseq), whereas this paper is solely based on imaging. I agree that performing scRNAseq is out of the scope of this paper, but the authors should be more precise in their comparison.

An example of this mix up is the sentence "While microglial expression in the early phase of development appears to recapitulate developmental programs (19), we did not observe the typical morphologies of developing microglia, or changes in process dynamics and responses to injury that could indicate a less mature phenotype." (line 591).

We revised this section and clarified the maturation of microglia in development versus the maturation of microglia with depletion and repopulation.

Also, what are the "typical morphologies of developing microglia"? and what is known about the motility of developing microglia?

We have explained the morphological and dynamic changes in microglia during development (ameboid morphologies and motile somas vs. processes in early life microglia) to compare to our findings in adult newly-born microglia.

Finally, the use of the word "profile" (line 593) is confusing, because it is usually related to the "transcriptional profile" but the authors seem to use it to refer to their own morphological results.

We removed the word profile when referring to the morphological results throughout the manuscript.

7. The paper on Mac2+ (possible) microglia progenitors, which is widely discussed in this paper, has not been peer-reviewed and I am unsure about the policies of eLife of citing papers from open repositories such as biorxiv.

We updated the references to include the published work.

Reviewer #2:

[…] A major concern is that most of the data in this manuscript simply confirmed already published experiments. This manuscript also provides new data related to brain replenishment after PLX-induced depletion of microglia. These data will certainly be of great interest for those working in the field of microglia function in the adult, but may have a limited impact outside of this community.

While we agree that some of our data confirms recently published findings, we are confident that the novel aspects of our experiments will not only add to the microglia repopulation field but to the microglia biology field altogether. We provide new information as to the dynamics of microglial division, showing that these divisions can be remarkably rapid and continuous. We also provide novel information on the maturation of newly generated microglia and show that their morphologies, surveillance and responses to injury are established very rapidly after repopulation. Lastly, we show that P2Y12 has a limited role in these processes, despite being a critical receptor for microglial homeostatic functions. An overall understanding of the basic biology and mechanism behind adult microglia biology will be beneficial in understanding how microglia self-renew in disease states.

Reviewer #3:

[…] 1. An important part of the article is based on the analysis of microglia called "doublet", which would be microglia in the process of proliferation. However, the authors do not provide a very clear definition of what a doublet is and how these doublets were identified. Clearly defined quantitative criteria would make this part more convincing. In addition, as a certain number of these doublets remain in the doublet state, without dividing, during the observation period (up to 30 days), it would be interesting to show that they indeed correspond to cells in the process of proliferation. A correlation between the identification of doublets in vivo and histochemical analysis of nuclear markers after fixation could help.

To address this comment, we stained and characterized doublets during the peak of division on day 2 of repopulation and now provide a quantitative analysis of the morphological features that distinguish doublets from singlets and control microglia (Figure 3). Additionally, we also stained these cells for Galectin 3, to determine whether the doublet morphology corresponded to the recently described Gal3 positive progenitor-like microglia that is resistant to CSF1R inhibition (Zhan et al. 2020). While we confirmed that Gal3 was indeed upregulated in a subset of microglia during the repopulation phase, it appeared that Gal3 was expressed equally in doublet and singlet cells (see new Supplementary Figure 6). This agrees with the findings in the Zhan study that described EdU incorporation equally in Gal3+ and Gal3- microglia during repopulation, suggesting that proliferation occurs in both of these types of microglia. Unfortunately, Ki67 labels very few microglia in our hands in repopulated tissue (and in the Zhan et al., 2020 – see Figure 5 supplement 1) precluding an analysis of proliferating cells and morphology. We did not attempt to use EdU as the experimental design requires a pulse/chase administration which would label many cells rather than just those actively dividing at the time of analysis.

2. The approach consisting in using the values of the repopulation dynamics obtained with monitoring microglia every 4 hours for 24 hours in a mathematical model (Figure 4) to test whether proliferation alone can explain the observations made with a monitoring less frequent (1 / day) but longer (30 days) (Figure 2) is interesting. Unfortunately, the description of the mathematical modeling is unclear and it is difficult as it is to understand if the results of this modeling actually support the authors' conclusion that "it is reasonable to believe that the repopulation.… came purely from local doublet cell division" (page 16).

We included a schematic that describes the mathematical model in its entirety in the supplementary figures section. In addition, we expanded on the mathematical section that accompanies figure 5 We also included a detailed description of the formula used for the model. This description was created and reviewed by statisticians Dr. Matthew McCall and Zachary Brehm both co-authors on the manuscript.

3. The authors tend to minimize the role of P2Y12. It is true that this receptor does not modify the dynamics of microglia repopulation. However, after repopulation the morphology of P2Y12 KO microglia is very different from that of wild type microglia. Suppl. Figure 4 clearly shows that at the end of repopulation (D30), P2Y12 KO microglia look more like the control, wild type and P2Y12 KO, microglia than do repopulating wild type microglia. Maybe this could be stressed a bit more clearly as this may be important for microglia-neuron interactions. As for wild type microglia (Figure 5A), pictures of P2Y12 KO microglia in control and at different stages of the repopulation should be shown.

Thank you for your comment. It is true that P2Y12 may play a role in the regulation of newly born microglia morphology. To address this comment, we altered the title of the paper, rewrote the abstract and discussion to reflect this point and included pictures of P2Y12 KO microglia in figure 6. Direct comparisons of CX3cr1 GFP/+ and P2Y12 KO animals are now presented in supplementary figures 4-5 and 9-13.

References:

1. Lowery, R.L., Tremblay, M.E., Hopkins, B.E., and Majewska, A.K. (2017). The microglial fractalkine receptor is not required for activity- dependent plasticity in the mouse visual system. Glia 65, 1744-1761. 10.1002/glia.23192.

2. Sipe, G.O.e.a. (2016). Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun 7, 10905. 10.1038/ncomms10905.

3. Stowell, R.D., Sipe, G.O., Dawes, R.P., Batchelor, H.N., Lordy, K.A., Whitelaw, B.S., Stoessel, M.B., Bidlack, J.M., Brown, E., Sur, M., and Majewska, A.K. (2019). Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nat Neurosci 22, 1782-1792.

10.1038/s41593-019-0514-0.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Source data for microglia turnover and migration in the physiological brain.
    Figure 1—source data 2. Source data for CSF1R inhibition in the adult brain.
    Figure 1—source data 3. Source data for the Cytokine panel conducted.
    Figure 2—source data 1. Source data of microglial repopulation after partial depletion.
    Figure 2—source data 2. Source data for the GFAP expression following microglial depletion.
    Figure 3—source data 1. Source data for microglial repopulation.
    elife-61173-fig3-data1.xlsx (180.8KB, xlsx)
    Figure 3—source data 2. Galectin three expression in microglia after repopulation.
    Figure 4—source data 1. Source data for microglia repopulation in mice imaged every 4 hr for 24 hr.
    Figure 5—source code 1. Code to generate the mathematical model simulation.
    Figure 5—source data 1. Source data for the mathematical modeling of microglial repopulation.
    Figure 6—source data 1. Source data for the morphology and soma area of newly born microglia.
    Figure 7—source data 1. Source data for newly born microglia motility, surveillance during depletion and repopulation.
    Figure 8—source data 1. Source data for newly-born microglia response to acute laser ablation injury.
    Transparent reporting form

    Data Availability Statement

    All data generated or analyzed during this study are included in the manuscript and supporting files.All MATLAB codes are available at https://github.com/majewska-lab.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES